<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.958" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">347</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 182.300 L93.120 182.300 "/>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M62.360 682.300 L105.610 682.300 "/>
  <g begin="text">
   <text y="77.103" x="62.362,68.86,75.358,80.362,84.862,87.859,91.36,95.86,99.856,103.852,106.354,109.351,111.853,115.849,118.018,125.02,129.016,136.018,140.518,143.515,148.015,150.184,154.18,158.68,163.18,165.349,167.851,170.848,173.35,177.85,180.352,184.348,186.517,191.017,195.013,199.513,203.509,206.011,208.513,213.013,217.009,219.178,225.181,227.35,231.346,235.342,237.844,240.346,243.847,246.016,253.018,257.014,261.514,263.683,268.183,272.179,274.348,278.344,280.513,284.509,287.506,290.008,292.51,295.012" svgx:width="0.72,0.72,0.56,0.5,0.33,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.78,0.44,0.78,0.5,0.33,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.33,0.28,0.5,0.28,0.44,0.25,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.78,0.44,0.5,0.25,0.5,0.44,0.25,0.44,0.25,0.44,0.33,0.28,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">AQP4-specific memory and triple negative B cells may be a criti-</text>
   <text y="88.101" x="62.362,66.358,70.354,72.856,75.376,78.877,83.377,87.877,90.874,94.87,98.866,101.386,105.886,108.883,111.403,117.406,123.904,128.908,130.933,137.431,143.929,148.933,153.433,156.43,159.427,163.927,170.425,172.945,177.445,180.442,184.942,189.442,193.942,197.938,200.44,204.94,209.44,211.96,216.46,218.962,222.958,226.459,233.461,237.457,241.957,244.459,248.455,251.956,254.458,257.959,260.479,264.475,268.975,273.475,275.995,280.495,282.997,286.993,291.493,294.013,298.009" svgx:width="0.44,0.44,0.28,0.25,0.39,0.5,0.5,0.33,0.44,0.44,0.25,0.5,0.33,0.25,0.67,0.72,0.56,0.25,0.72,0.72,0.56,0.5,0.33,0.33,0.5,0.72,0.25,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.5,0.28,0.44,0.39,0.78,0.44,0.5,0.28,0.44,0.39,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.44,0.5,0.25,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cal source of CNS AQP4-IgG producing plasmablasts and play a </text>
   <text y="99.099" x="62.362,65.359,69.859,72.361,76.357,78.517,81.019,85.519,87.679,90.181,94.681,98.677,100.837,103.339,107.839,110.341,112.843,115.345,119.341,121.843,124.345,128.845,133.345,135.505,140.005,143.002,145.162,151.66,159.661,166.159,168.319,170.821,174.817,178.318,180.82,185.32,189.82,193.321,195.571,197.731,205.732,210.232,214.732,217.234,219.736,224.236,227.233,229.735,234.235,238.735,240.895,243.397,247.897,251.893,255.394,259.39,261.55,266.05,270.046,273.043,275.545,280.045,284.545,288.541,291.538,295.534,298.036" svgx:width="0.33,0.5,0.28,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.72,0.89,0.72,0.25,0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25,0.25,0.89,0.5,0.5,0.28,0.28,0.5,0.33,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.39,0.44,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">role in the initiation of NMO lesions. Monitoring these peripheral </text>
   <text y="110.097" x="62.362,66.862,69.364,73.864,78.364,82.864,85.132,89.632,94.132,98.632,103.132,105.634,109.63,112.132,114.634,119.134,123.634,127.135,129.403,136.405,140.401,144.901,147.169,151.669,154.666,159.166,163.666,167.662,169.93,174.43,177.931,181.927,184.924,189.424,191.926,194.194,197.191,201.691,204.688,206.956,210.952,214.453,217.954,221.95,225.451,228.952,231.454,235.954,240.454,242.722,247.222,249.724,253.225,257.221,261.217,264.718,268.714,270.982,274.978,278.974,281.476,283.978,288.478,290.98,293.482,297.982" svgx:width="0.5,0.28,0.5,0.5,0.5,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.78,0.44,0.5,0.25,0.5,0.33,0.5,0.5,0.44,0.25,0.5,0.39,0.44,0.33,0.5,0.28,0.25,0.33,0.5,0.33,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">blood populations may prove useful for assessing disease activity </text>
   <text y="121.095" x="62.362,66.358,70.858,75.358,77.608,80.11,84.61,88.606,91.603,95.599,100.099,104.014" svgx:width="0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and therapy.</text>
   <text y="148.095" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P635</text>
   <text y="159.093" x="62.362,69.364,75.367,81.865,84.115,88.111,90.613,95.113,98.614,102.115,104.365,108.865,113.365,115.615,120.115,122.617,125.119,129.115,131.617,135.613,139.114,141.364,145.864,150.868,155.872,158.122,162.118,167.122,171.622,174.124,178.12,182.62,187.624,195.121,199.117,204.121,207.118,211.618,214.12,216.37,220.87,224.371,227.872,232.372,236.368,238.87,243.37,246.367,248.869,253.369,258.373,261.874" svgx:width="0.78,0.67,0.72,0.25,0.44,0.28,0.5,0.39,0.39,0.25,0.5,0.5,0.25,0.5,0.28,0.28,0.44,0.28,0.44,0.39,0.25,0.5,0.56,0.56,0.25,0.44,0.56,0.5,0.28,0.44,0.5,0.56,0.83,0.44,0.56,0.33,0.5,0.28,0.25,0.5,0.39,0.39,0.5,0.44,0.28,0.5,0.33,0.28,0.5,0.56,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">HLA class 11 alleles and environmental associations </text>
   <text y="170.091" x="62.362,68.86,71.362,74.359,79.363,81.613,86.617,90.613,95.617,99.613,104.113,111.61,116.11,120.106,122.608,125.11,128.107,130.609,134.11,136.36,140.86,145.864,148.861,151.363,155.359,159.859,162.109,164.611,169.615,171.865,175.366,180.37,185.374,187.876,192.376,197.38,199.63,204.634,209.134,214.138,219.142,221.644,226.144,229.141,231.643,236.143" svgx:width="0.72,0.28,0.33,0.56,0.25,0.56,0.44,0.56,0.44,0.5,0.83,0.5,0.44,0.28,0.28,0.33,0.28,0.39,0.25,0.5,0.56,0.33,0.28,0.44,0.5,0.25,0.28,0.56,0.25,0.39,0.56,0.56,0.28,0.5,0.56,0.25,0.56,0.5,0.56,0.56,0.28,0.5,0.33,0.28,0.5,0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">with neuromyelitis optica in Indian population</text>
   <text y="181.089" x="62.362,67.861,70.111,75.115,79.111,83.611,88.111,90.613" svgx:width="0.61,0.25,0.56,0.44,0.5,0.5,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">L Pandit</text>
   <text y="178.583" x="93.115" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="181.103" x="96.04,98.29,100.54,106.543,108.793,116.794,120.79,123.292,125.794" svgx:width="0.25,0.25,0.67,0.25,0.89,0.44,0.28,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, C Malli</text>
   <text y="178.583" x="128.296" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="181.103" x="131.221,133.471,135.721,142.219,144.469,150.967,153.964,159.967,164.467,168.967,173.467" svgx:width="0.25,0.25,0.72,0.25,0.72,0.33,0.67,0.5,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A D’Cunha</text>
   <text y="178.583" x="177.462" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="181.103" x="180.387,182.637,184.887,189.891,192.141,200.142,204.642,208.143,210.645,214.641,217.638" svgx:width="0.25,0.25,0.56,0.25,0.89,0.5,0.39,0.28,0.44,0.33,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Mustafa</text>
   <text y="178.583" x="221.634" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="181.103" x="224.559,226.809,229.059,235.062,237.312,243.81,248.31,252.81,257.31,261.306" svgx:width="0.25,0.25,0.67,0.25,0.72,0.5,0.5,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, R Kunder</text>
   <text y="178.583" x="264.302" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="189.581" x="62.36" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="192.103" x="65.287,71.29,75.79,78.04,84.538,88.534,93.034,97.534,101.53,103.78,111.277,115.273,119.773,122.275,126.271,130.771,133.273,135.523,141.022,145.018,149.518,154.018,158.014,164.512,168.508,170.758,173.008,179.011,181.513,184.015,186.517,190.513,192.763,199.261,203.761,206.263,210.259,214.255,217.756,221.257,223.759,226.261,230.257,232.507,234.757,240.76,244.756,249.256,252.757,257.257,259.759,264.259,268.759,272.755,275.005" svgx:width="0.67,0.5,0.25,0.72,0.44,0.5,0.5,0.44,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.61,0.44,0.5,0.5,0.44,0.72,0.44,0.25,0.25,0.67,0.28,0.28,0.28,0.44,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">KS Hegde Medical Academy, Nitte University, Neurology, </text>
   <text y="203.101" x="62.362,69.859,74.359,78.859,83.359,87.859,90.361,94.861,98.362,102.358,104.608,106.858,109.855,114.355,118.855,121.357" svgx:width="0.83,0.5,0.5,0.5,0.5,0.28,0.5,0.39,0.44,0.25,0.25,0.33,0.5,0.5,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Mangalore, India</text>
   <text y="230.101" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="230.101" x="114.913,117.91,120.412,122.617,125.119,128.62,130.825,135.325,139.825,143.821,146.323,150.319,154.315,157.312,159.517,166.015,170.515,174.511,177.013,181.513,185.509,188.506,190.711,193.213,197.713,201.709,204.706,208.702,210.907,214.903,217.9,221.896,224.101,228.601,232.597,237.097,241.093,243.595,246.097,250.093,252.298,256.294,260.794,265.294,267.499,271.495,275.995,280.495,282.997,285.994,290.494,294.994" svgx:width="0.33,0.28,0.25,0.28,0.39,0.25,0.5,0.5,0.44,0.28,0.44,0.44,0.33,0.25,0.72,0.5,0.44,0.28,0.5,0.44,0.33,0.25,0.28,0.5,0.44,0.33,0.44,0.25,0.44,0.33,0.44,0.25,0.5,0.44,0.5,0.44,0.28,0.28,0.44,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">It is unclear whether there are genetic and environ-</text>
   <text y="241.099" x="62.362,69.364,73.36,77.86,80.362,84.358,86.86,88.804,92.8,96.301,99.802,104.302,108.298,110.8,114.796,117.298,119.8,124.3,128.8,132.301,134.245,140.743,143.245,145.747,150.247,152.191,156.691,160.687,165.187,168.184,172.684,179.686,184.186,188.182,190.684,193.186,195.688,198.19,201.691,203.635,208.135,212.635,215.137,217.639,221.635,225.631,227.575,230.572,237.07,245.071,251.569,254.566,256.51,261.01,265.006,268.003,270.505,273.007,277.003,281.503,284.005,288.001,290.998,293.5,298.0" svgx:width="0.78,0.44,0.5,0.28,0.44,0.28,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.44,0.5,0.33,0.5,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.5,0.5,0.28,0.28,0.44,0.44,0.25,0.33,0.72,0.89,0.72,0.33,0.25,0.5,0.44,0.33,0.28,0.28,0.44,0.5,0.28,0.44,0.33,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mental associations with neuromyelitis optica (NMO) particularly </text>
   <text y="252.097" x="62.362,64.864,69.364,71.614,74.611,79.111,83.611,86.113,90.109,94.609,96.859,101.359,105.859,110.359,114.859,117.361,121.357,123.859,126.361,130.861,135.361" svgx:width="0.28,0.5,0.25,0.33,0.5,0.5,0.28,0.44,0.5,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">in Indian population.</text>
   <text y="263.095" x="62.362,69.679,74.998,78.31,82.621,86.932,90.244,93.061,97.876,102.187,106.003,109.315" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="263.095" x="112.663,117.847,122.662,124.912,126.01,130.825,135.136,137.953,142.264,145.576,152.893,155.71,160.525,164.836,167.086,168.184,174.997,180.811,187.129,189.379,190.477,197.29,203.608,209.926,214.741,222.058,224.308,225.406,232.219,239.032,245.35,250.165,252.415,253.513,257.824,260.641,263.458,267.769,270.586,274.897,277.147,278.245,282.556,286.372,290.188,295.003" svgx:width="0.61,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.25,0.55,0.72,0.61,0.72,0.25,0.55,0.72,0.67,0.67,0.5,0.78,0.25,0.55,0.72,0.72,0.67,0.5,0.25,0.55,0.44,0.28,0.28,0.44,0.28,0.44,0.25,0.55,0.44,0.39,0.39,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To determine HLA DRB1&amp; DQB1 allele asso-</text>
   <text y="274.093" x="62.362,66.673,69.49,73.801,76.618,79.435,84.25,89.065,92.881,95.212,102.025,104.842,107.659,112.474,114.805,121.618,129.934,136.747,139.312,141.148,147.961,152.776,157.591,160.408,163.225,166.042,170.857,175.672,179.983,182.8,185.617,190.432,192.763,195.58,200.395,204.706,207.037,210.349,215.164,217.981,222.292,224.623,229.438,232.75,235.081,239.392,244.207,247.024,249.841,254.656,259.471,264.286,269.101,273.916,276.247,280.558,285.373,290.188,295.003" svgx:width="0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.89,0.72,0.25,0.25,0.72,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.5,0.28,0.44,0.25,0.5,0.33,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ciations with NMO. Additionally the role of childhood expo-</text>
   <text y="285.091" x="62.362,66.178,70.993,74.305,78.616,80.866,83.512,86.329,91.144,93.394,96.04,99.856,107.173,111.988,116.803,119.62,124.435,129.25,131.815,134.065,136.711,139.528,144.343,147.655,151.966,156.277,159.094,161.911,166.726,171.541,175.357,177.922,180.172,182.818,187.633,190.45,194.761,197.578,199.828,202.474,206.785,211.6,216.415,218.665,221.311,225.127,229.942,234.757,237.007,239.653,243.964,248.779,253.594,258.409,262.225,267.04,270.352,274.663,276.913,279.559,286.372,290.683,293.995,297.991" svgx:width="0.39,0.5,0.33,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.39,0.78,0.5,0.5,0.28,0.5,0.5,0.25,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.25,0.55,0.5,0.28,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.39,0.5,0.33,0.44,0.25,0.55,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sure to smoking, infections, diet and sun exposure were </text>
   <text y="296.089" x="62.362,66.673,71.488,75.799,78.616,83.431,87.742,90.559,94.87,99.685" svgx:width="0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">evaluated.</text>
   <text y="307.087" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="307.087" x="102.457,106.957,111.457,113.707,115.057,119.053,123.553,128.053,130.555,133.057,135.307,136.648,141.148,145.144,147.646,150.148,154.144,158.644,161.146,164.647,166.897,168.247,171.244,173.746,178.246,182.242,184.744,189.244,193.744,196.246,200.746,205.246,207.496,208.837,213.337,217.837,224.839,228.835,231.337,235.333,238.834,241.831,244.081,245.422,251.92,254.422,256.924,261.424,263.674,265.024,268.021,272.017,274.519,278.515,283.015,286.516,289.018,293.518,298.018" svgx:width="0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.78,0.44,0.28,0.44,0.39,0.33,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">93 adult patients (including 24males) with relapsing </text>
   <text y="318.085" x="62.362,68.86,76.861,83.359,85.861,88.759,95.257,103.258,109.756,114.76,117.658,122.158,124.66,128.161,132.661,135.658,140.158,144.154,147.151,150.652,153.55,160.048,164.044,167.041,171.037,173.935,177.931,182.431,186.931,190.432,194.428,198.928,201.178,203.581,210.079,217.081,221.581,226.081,230.581,233.479,235.981,240.481,244.477,251.479,254.377,258.877,263.377,265.627,270.127,277.624,280.522,287.02,291.016,294.013,298.009" svgx:width="0.72,0.89,0.72,0.28,0.25,0.72,0.89,0.72,0.56,0.25,0.5,0.28,0.39,0.5,0.33,0.5,0.44,0.33,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.5,0.39,0.44,0.5,0.25,0.25,0.72,0.78,0.5,0.5,0.5,0.25,0.28,0.5,0.44,0.78,0.25,0.5,0.5,0.25,0.5,0.83,0.25,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NMO/ NMOS disorders were chosen. Among them 47.3% were </text>
   <text y="329.083" x="62.362,65.863,69.859,72.856,77.356,81.856,86.356,89.857,92.359,94.861,97.363,101.863,105.859,108.109,111.259,114.256,118.756,121.753,124.003,127.153,133.651,141.652,148.15,151.147,154.144,158.644,165.142,167.392,170.542,175.042,179.542,181.792,184.942,187.939,190.441,194.941,198.937,203.437,205.687,208.837,212.833,216.829,219.331,221.833,224.083,227.233,231.733,235.729,239.23,243.226,247.726,249.976,253.126,257.122,260.623,264.124,268.12,272.035,274.285,276.535,279.523,285.022,289.522,293.518,298.018" svgx:width="0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.72,0.89,0.72,0.33,0.33,0.5,0.72,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.28,0.5,0.44,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.25,0.55,0.5,0.44,0.39,0.44,0.5,0.25,0.55,0.44,0.39,0.39,0.44,0.5,0.25,0.25,0.55,0.61,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">seropositive for NMO-IgG by fixed cell based assay. They </text>
   <text y="340.081" x="62.362,64.864,69.364,73.36,75.862,80.362,84.862,88.858,93.358,95.608,97.57,104.068,112.069,118.567,120.817,122.779,127.279,129.781,133.777,138.277,142.777,147.277,150.778,154.774,159.274,161.524,163.486,167.986,172.486,174.736,176.536,184.672,187.174,191.674,196.174,200.17,203.167,207.163,211.663,216.163,220.159,224.659,226.909,228.871,233.371,237.871,242.371,246.871,249.121,251.083,255.079,258.076,260.578,263.08,267.076,270.073,272.575,276.571,278.821,280.783,283.78,288.28,292.78,295.777,298.027" svgx:width="0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.72,0.89,0.72,0.25,0.55,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.94,0.28,0.5,0.5,0.44,0.33,0.44,0.5,0.5,0.44,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.55,0.44,0.33,0.28,0.28,0.44,0.33,0.28,0.44,0.25,0.55,0.33,0.5,0.5,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">included NMO diagnosed by Wingerchuck 2006 criteria (61), </text>
   <text y="351.079" x="62.362,65.359,69.355,73.351,77.851,80.848,83.845,87.841,92.341,94.843,96.814,103.816,108.316,112.312,114.814,117.316,119.818,122.32,125.821,127.792,134.29,136.792,139.294,143.794,145.774,148.276,152.776,157.276,161.776,163.747,167.743,172.243,175.24,179.74,181.711,184.213,188.209,191.71,194.212,198.712,203.212,206.713,208.693,211.69,215.857,220.357,223.354,225.604,227.575,230.572,234.568,238.564,243.064,246.061,249.058,253.054,257.554,260.056,262.027,266.527,271.027,273.529,276.031,280.027,281.998,286.498,290.494,294.994" svgx:width="0.33,0.44,0.44,0.5,0.33,0.33,0.44,0.5,0.28,0.25,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.28,0.5,0.5,0.5,0.25,0.44,0.5,0.33,0.5,0.25,0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25,0.33,0.5,0.5,0.33,0.25,0.25,0.33,0.44,0.44,0.5,0.33,0.33,0.44,0.5,0.28,0.25,0.5,0.5,0.28,0.28,0.44,0.25,0.5,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">recurrent myelitis with long cord lesions (11), recurrent optic neu-</text>
   <text y="362.077" x="62.362,65.359,67.861,70.363,72.865,76.366,78.616,79.75,82.747,87.247,91.747,94.744,96.994,98.128,102.124,106.624,111.124,113.374,114.508,118.009,122.005,125.002,129.502,131.752,132.886,137.386,141.886,145.387,147.889,150.391,152.893,157.393,161.389,163.639,164.773,167.77,171.766,175.762,180.262,183.259,186.256,190.252,194.752,197.254,199.504,200.638,203.14,207.64,214.642,218.638,221.635,225.631,229.627,232.129,234.631,239.131,243.127,245.377,246.511,251.011,255.007,262.009,266.509,270.505,273.007,275.509,280.009,284.005,286.507,289.009,293.509,298.009" svgx:width="0.33,0.28,0.28,0.28,0.39,0.25,0.55,0.33,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.44,0.33,0.5,0.25,0.55,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.55,0.33,0.44,0.44,0.5,0.33,0.33,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.78,0.44,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ritis (20) and sero positive recurrent tumefactive demyelination </text>
   <text y="373.075" x="62.362,65.359,69.859,72.856,75.106,76.825,83.323,89.326,95.329,99.829,106.831,108.541,115.039,121.537,127.54,130.537,132.247,136.243,138.745,141.247,145.243,147.745,151.741,153.451,157.951,161.947,166.447,170.947,173.449,177.949,182.449,184.951,189.451,193.951,195.67,202.168,206.164,209.665,211.375,215.875,219.871,222.868,225.865,230.365,233.362,240.364,244.36,248.86,250.57,253.072,257.572,259.291,263.791,268.291,270.001,274.501,278.497,280.999,283.501,287.497,291.997,294.499,298.0" svgx:width="0.33,0.5,0.33,0.25,0.25,0.72,0.67,0.67,0.5,0.78,0.25,0.72,0.72,0.67,0.33,0.25,0.44,0.28,0.28,0.44,0.28,0.44,0.25,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(1). DRB1&amp; DQBI allele genotyping was performed in 93 patients </text>
   <text y="384.073" x="62.362,66.358,70.858,75.358,78.211,82.711,87.211,91.711,94.564,99.064,103.06,107.056,109.558,112.06,116.56,121.06,123.913,127.909,132.409,136.909,139.411,142.408,146.908,149.41,152.911,155.764,160.264,164.764,167.617,172.621,178.624,184.627,187.48,191.476,195.976,200.476,203.329,207.325,211.825,215.821,218.323,222.823,226.819,230.815,235.315,238.168,242.668,247.168,250.021,256.519,263.017,268.021,274.519,281.017,286.021,291.52,298.018" svgx:width="0.44,0.5,0.5,0.25,0.5,0.5,0.5,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.39,0.25,0.5,0.5,0.25,0.56,0.67,0.67,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.25,0.5,0.5,0.25,0.72,0.72,0.56,0.72,0.72,0.56,0.61,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and 200 healthy controls by PCR and analyzed by UNPHASED </text>
   <text y="395.071" x="62.362,66.862,69.112,73.612,75.862,80.362,82.612,83.422,86.923,91.423,94.42,96.922,103.42,107.416,110.413,114.409,116.659,118.909,119.719,125.218,129.718,134.218,136.72,139.717,144.217,148.717,155.719,159.715,164.215,166.717,170.713,173.215,175.465,176.275,180.271,184.771,189.271,193.771,197.272,201.772,204.769,208.765,211.015,211.825,216.325,218.827,222.328,224.83,229.33,232.327,236.827,239.077,239.887,246.385,250.381,253.882,256.132,256.942,261.442,265.942,268.444,272.44,274.942,279.442,283.438,287.938,290.188,290.998,293.5,298.0" svgx:width="0.5,0.25,0.5,0.25,0.5,0.25,0.55,0.39,0.5,0.33,0.28,0.72,0.44,0.33,0.44,0.25,0.25,0.55,0.61,0.5,0.5,0.28,0.33,0.5,0.5,0.78,0.44,0.5,0.28,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.5,0.39,0.5,0.33,0.44,0.25,0.55,0.5,0.28,0.39,0.28,0.5,0.33,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.5,0.28,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">3.0.8 software. Environmental exposure history was obtained in </text>
   <text y="406.069" x="62.362,66.358,68.86,71.362,73.612,74.818,79.318,83.314,85.816,88.318,92.314,96.814,99.316,102.817,105.067,106.273,110.269,114.769,119.269,121.519,122.725,129.727,133.723,136.225,140.221,144.721,148.717,153.217,155.467,156.673,160.669,165.169,169.669,172.171,175.168,179.668,182.17,185.671,187.921,189.127,191.629,196.129,199.126,203.626,208.126,212.626,217.126,219.376,220.582,224.578,226.828,228.034,232.534,236.53,239.032,241.534,246.034,250.03,252.532,256.528,261.028,263.278,264.484,268.984,273.484,277.48,280.981,283.483,285.985,290.485,294.985" svgx:width="0.44,0.28,0.28,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.78,0.44,0.28,0.44,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.39,0.25,0.55,0.28,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">all patients and matched controls through a validated question-</text>
   <text y="417.067" x="62.362,66.862,70.858,73.36,76.357,80.353,82.603,83.539,88.039,92.539,94.789,95.725,100.225,104.221,107.218,110.719,115.219,119.719,123.715,126.217,128.46699999999998,129.403,131.905,136.405,138.907,142.903,145.9,150.4,152.902,156.898,163.396,166.897,169.147,170.083,174.079,178.579,183.079,185.329,186.265,189.262,193.258,196.759,201.259,203.761,206.263,209.764,212.014,212.95,216.946,221.446,225.442,227.944,232.444,236.44,240.436,244.936,247.186,248.122,252.622,257.122,259.372,260.308,264.304,268.804,271.306,273.556,274.492,277.993,282.493,286.993,290.989,293.986,297.982" svgx:width="0.5,0.44,0.28,0.33,0.44,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.39,0.5,0.5,0.44,0.28,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.5,0.28,0.44,0.72,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.44,0.39,0.5,0.28,0.28,0.39,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.25,0.55,0.39,0.5,0.5,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">naire by personal interviews and results analyzed by chi square </text>
   <text y="428.065" x="62.362,64.864,68.86,72.361,74.863,77.113,81.109,85.609,90.109,92.359,99.361,103.861,106.363,108.865,111.367,115.867,119.863,122.86,125.362,129.358,131.86,135.856,138.106,142.102,146.602,150.598,153.1,157.6,161.101,163.603,167.104" svgx:width="0.28,0.44,0.39,0.28,0.25,0.44,0.5,0.5,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.44,0.33,0.28,0.44,0.28,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">test and multivariate analysis.</text>
   <text y="439.063" x="62.362,68.905,72.946,76.492,81.541,84.088,87.13,90.676,93.718" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="439.063" x="98.929,105.472,113.518,120.061,122.311,125.263,129.808,133.849,136.396,138.943,142.984,147.529,150.076,153.622,155.872,158.833,163.378,167.419,171.964,174.214,177.166,180.712,183.259,187.804,192.349,194.896,197.938,200.485,204.526,208.567,213.112,215.659,217.909,220.87,224.911,227.458,230.005,234.046,236.593,240.634,242.884,245.845,248.887,251.929,255.97,260.515,265.06,269.101,273.646,277.687,282.232,284.482,287.443,290.485,295.03,298.027" svgx:width="0.72,0.89,0.72,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.44,0.28,0.28,0.44,0.28,0.44,0.25,0.55,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.55,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NMO patients had significant allele frequency for </text>
   <text y="450.061" x="62.362,68.905,74.953,81.001,85.546,90.091,94.636,99.181,101.377,104.419,108.964,114.085,116.281,120.826,123.022,127.567,129.763,134.308" svgx:width="0.72,0.67,0.67,0.5,0.5,0.5,0.5,0.25,0.33,0.5,0.56,0.25,0.5,0.25,0.5,0.25,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">DRB1*03 (p= 4 x 10</text>
   <text y="447.583" x="138.849,140.826" svgx:width="0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">-5</text>
   <text y="450.103" x="143.781,146.076,148.272,154.815,160.863,165.984,168.18,172.725,175.02,179.565,181.86,184.056,190.104,193.146,198.267,200.463,205.008,207.303,211.848,214.89,219.435,223.98,226.275,230.82,233.862,235.896,244.437,248.982,253.023,257.568,259.764,266.307,274.353,280.896,283.938,286.98,291.525,298.023" svgx:width="0.25,0.25,0.72,0.67,0.56,0.25,0.5,0.25,0.5,0.25,0.25,0.67,0.33,0.56,0.25,0.5,0.25,0.5,0.33,0.5,0.5,0.25,0.5,0.33,0.25,0.94,0.5,0.44,0.5,0.25,0.72,0.89,0.72,0.33,0.33,0.5,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, OR= 6.9, CI= 2.7-17.3) When NMO-IgG </text>
   <text y="461.101" x="62.367,66.912,71.457,75.003,77.55,80.097,82.644,87.189,91.23,93.48,94.47,99.015,103.056,105.603,108.15,112.191,116.736,119.283,122.829,125.079,126.069,130.11,132.657,137.202,141.747,145.788,148.038,149.028,155.571,159.612,162.654,166.695,168.945,169.935,173.976,178.521,182.562,185.109,189.654,193.695,197.736,202.281,204.531,205.521,208.068,212.613,215.16,218.706,220.956,221.946,225.987,229.533,233.079,237.624,241.665,244.212,248.253,250.8,253.347,257.892,262.437,264.687,265.677,270.222,274.263,277.305,280.851,283.398,286.944,289.491,293.532,298.032" svgx:width="0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.44,0.28,0.5,0.5,0.44,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.28,0.39,0.25,0.55,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.39,0.28,0.39,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">positive patients alone were analyzed this association persisted </text>
   <text y="472.099" x="62.367,65.409,69.954,75.075,77.73,82.275,84.57,89.115,93.66,98.205,100.5,103.155,109.698,115.746,120.867,123.522,127.734,132.279,134.574,139.119,141.414,144.069,150.117,153.159,158.28,160.935,165.48,167.775,172.32,175.362,178.017,182.562,187.107,189.402,193.947,196.989,199.644,201.939,204.099,210.147,212.802,216.348,218.895,225.942,228.489,231.036,235.077,238.119,240.774,244.815,248.361,251.907,256.452,260.493,263.04,267.081,269.628,272.175,276.72,281.265,283.92,290.463,294.504,298.005" svgx:width="0.33,0.5,0.56,0.25,0.5,0.25,0.5,0.5,0.5,0.25,0.25,0.72,0.67,0.56,0.25,0.5,0.5,0.25,0.5,0.25,0.25,0.67,0.33,0.56,0.25,0.5,0.25,0.5,0.33,0.25,0.5,0.5,0.25,0.5,0.33,0.25,0.25,0.25,0.72,0.25,0.39,0.28,0.78,0.28,0.28,0.44,0.33,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(p= 0.002, OR= 11.3, CI= 3.1- 40.6) . A similar association was </text>
   <text y="483.097" x="62.367,65.913,69.954,73.995,78.54,80.79,81.564,84.606,89.151,92.193,94.443,95.217,101.76,107.808,113.856,118.401,122.946,127.491,132.036,134.286,135.06,139.101,141.648,144.195,148.236,150.783,154.824,157.074,157.848,160.89,163.14,163.914,168.459,173.58,175.83,176.604,181.149,183.444,187.989,192.534,197.079,201.624,203.919,206.169,206.943,213.486,219.534,224.655,226.905,227.679,232.224,234.519,239.064,241.359,243.609,244.383,250.431,253.473,258.594,260.844,261.618,266.163,268.458,273.003,276.045,278.295,279.069,283.614,288.159,290.454,294.999,297.996" svgx:width="0.39,0.44,0.44,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.72,0.67,0.67,0.5,0.5,0.5,0.5,0.25,0.55,0.44,0.28,0.28,0.44,0.28,0.44,0.25,0.55,0.33,0.25,0.55,0.5,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.55,0.72,0.67,0.56,0.25,0.55,0.5,0.25,0.5,0.25,0.25,0.55,0.67,0.33,0.56,0.25,0.55,0.5,0.25,0.5,0.33,0.25,0.55,0.5,0.5,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">seen for DRB1*10 allele ( p= 0.0002, OR= 4.9, CI= 2.1- 12.2) </text>
   <text y="494.095" x="62.367,68.91,73.455,76.002,80.043,84.588,86.838,88.485,91.527,95.568,102.615,106.656,109.203,113.748,117.789,122.334,124.584,126.231,129.777,132.324,136.869,141.414,143.961,147.003,149.55,153.591,157.632,162.177,164.724,166.974,168.621,172.662,175.704,178.251,182.292,185.334,187.584,189.231,193.272,197.817,200.364,204.909,208.455,211.002,213.549,218.094,222.639,224.889,226.536,229.578,234.123,237.165,239.415,241.062,247.605,253.653,259.701,264.246,268.791,273.336,277.881,280.176,282.426,283.911,289.455,294.0,297.996" svgx:width="0.72,0.5,0.28,0.44,0.5,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.44,0.5,0.28,0.5,0.39,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.72,0.67,0.67,0.5,0.5,0.5,0.5,0.25,0.25,0.55,0.61,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">which remained significant after adjusting for DRB1*03. The </text>
   <text y="505.093" x="62.367,66.408,70.953,78.0,85.047,89.592,94.137,96.387,99.411,103.956,107.997,112.542,115.089,119.634,122.181,126.726,131.271,135.312,138.858,141.108,144.132,147.678,151.719,155.76,160.305,162.555,165.579,172.122,176.163,179.205,183.246,185.496,188.52,195.063,201.111,207.159,211.704,216.249,220.794,225.339,228.381,230.631,233.655,240.198,246.741,252.789,257.334,261.879,266.424,270.969,275.514,280.059,282.309,285.333,288.375,292.92,297.996" svgx:width="0.44,0.5,0.78,0.78,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.39,0.25,0.55,0.39,0.44,0.44,0.5,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.72,0.67,0.67,0.5,0.5,0.5,0.5,0.33,0.25,0.55,0.72,0.72,0.67,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.33,0.5,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">common haplotypes seen were DRB1*10- DQB1*0602 (p= </text>
   <text y="516.091" x="62.367,66.912,69.207,73.752,78.297,82.842,87.387,89.682,91.932,93.714,100.257,106.305,111.426,113.676,115.458,120.003,122.298,126.843,129.885,133.926,138.471,143.016,145.266,147.048,153.591,159.639,165.687,170.232,174.777,179.322,183.867,186.909,189.159,190.941,197.484,204.027,210.075,214.62,219.165,223.71,228.255,232.8,237.345,239.595,241.377,244.419,248.964,254.085,256.33500000000004,258.117,262.662,264.957,269.502,274.047,276.342,278.592,280.374,286.917,292.965,298.041" svgx:width="0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.55,0.72,0.67,0.56,0.25,0.55,0.5,0.25,0.5,0.33,0.44,0.5,0.5,0.25,0.55,0.72,0.67,0.67,0.5,0.5,0.5,0.5,0.33,0.25,0.55,0.72,0.72,0.67,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.33,0.5,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.25,0.25,0.55,0.72,0.67,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">0.0003, OR= 5.2)and DRB1*03- DQB1*0201 (p= 0.03, OR= </text>
   <text y="527.089" x="62.367,66.912,69.207,73.752,78.297,81.339,83.229,85.524,87.252,92.796,96.837,101.382,105.423,107.97,112.011,115.053,117.6,121.641,126.186,128.076,132.621,135.168,139.209,141.756,143.646,146.688,151.233,156.354,158.244,162.789,165.084,169.629,174.174,177.216,179.511,181.401,183.948,188.493,192.039,196.584,199.464,202.506,205.053,209.094,211.641,215.682,220.227,222.774,224.664,229.209,231.756,234.303,238.344,245.391,247.938,252.483,254.373,260.916,262.806,265.848,268.395,272.436,276.981,278.871,281.913,286.458,291.003,295.548,298.05" svgx:width="0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.25,0.72,0.44,0.5,0.44,0.28,0.44,0.33,0.28,0.44,0.5,0.25,0.5,0.28,0.44,0.28,0.25,0.33,0.5,0.56,0.25,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.28,0.5,0.39,0.5,0.33,0.33,0.28,0.44,0.28,0.44,0.5,0.28,0.25,0.5,0.28,0.28,0.44,0.78,0.28,0.5,0.25,0.72,0.25,0.33,0.28,0.44,0.5,0.25,0.33,0.5,0.5,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">1.74) . Vegetarian diet (p= 0.03), insufficient vitamin D rich food/ </text>
   <text y="538.087" x="62.367,65.913,70.458,75.003,79.548,82.095,86.136,93.183,97.224,101.769,104.316,107.862,110.013,112.56,117.105,119.256,123.801,126.348,130.389,132.936,135.087,138.129,142.674,147.795,149.946,154.491,156.786,161.331,165.876,168.918,171.069,175.11,179.655,184.2,186.351,190.896,195.441,199.986,203.028,205.179,208.725,213.27,217.815,219.966,224.007,228.552,233.097,237.642,241.188,245.733,248.775,252.816,254.967,258.009,262.554,267.675,269.826,274.371,276.666,281.211,285.756,288.798,290.949,293.496,297.996" svgx:width="0.39,0.5,0.5,0.5,0.28,0.44,0.78,0.44,0.5,0.28,0.39,0.25,0.28,0.5,0.25,0.5,0.28,0.44,0.28,0.25,0.33,0.5,0.56,0.25,0.5,0.25,0.5,0.5,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.39,0.5,0.5,0.25,0.44,0.5,0.5,0.5,0.39,0.5,0.33,0.44,0.25,0.33,0.5,0.56,0.25,0.5,0.25,0.5,0.5,0.33,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">supplements in diet (p= 0.01) and poor sun exposure (p= 0.01) in </text>
   <text y="549.085" x="62.367,66.408,70.953,73.5,76.047,80.592,85.137,89.682,94.227,98.772,101.022,102.21,108.753,112.794,115.836,119.877,122.127,123.315,126.861,129.408,133.953,138.498,141.045,144.087,146.634,150.675,154.716,159.261,161.808,164.355,168.9,171.15,172.338,176.379,179.925,183.471,188.016,192.057,194.604,198.645,201.192,205.233,209.778,212.028,213.216,219.759,222.306,224.853,229.398,231.648,232.836,239.379,247.425,253.968,256.263,258.513,259.701,266.244,268.791,272.337,274.884,279.429,282.471,287.016,289.266,290.454,294.999,297.996" svgx:width="0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.55,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.72,0.89,0.72,0.25,0.25,0.55,0.72,0.28,0.39,0.28,0.5,0.33,0.5,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">childhood were significantly associated with NMO. History of </text>
   <text y="560.083" x="62.367,66.408,70.953,73.5,76.047,80.592,85.137,89.682,94.227,98.772,101.022,102.318,104.865,109.41,112.452,116.493,120.534,123.081,125.628,130.173,134.718,138.264,140.514,141.81,145.851,150.396,154.941,157.191,158.487,162.033,169.08,173.625,178.17,180.717,185.262,189.807,192.057,193.353,196.395,200.436,204.477,207.024,209.571,214.116,218.157,220.704,222.954,224.25,228.795,232.836,236.382,239.928,242.475,247.02,251.061,254.103,256.353,257.649,261.195,265.74,270.285,276.828,280.869,285.414,287.664,288.96,293.505,298.005" svgx:width="0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.78,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.25,0.55,0.5,0.44,0.39,0.39,0.28,0.5,0.44,0.33,0.25,0.55,0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">childhood infections and smoking (active/ passive) showed no </text>
   <text y="571.081" x="62.367,66.408,69.954,73.5,78.045,82.086,84.633,88.674,91.221,93.768,98.313,102.858" svgx:width="0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">association.</text>
   <text y="582.079" x="62.367,68.865,73.365,78.369,82.365,84.867,89.871,93.372,95.874,100.374,105.378,108.879,111.876" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="582.079" x="113.973,120.471,124.467,128.967,132.963,135.465,137.967,141.963,144.06,148.056,152.556,157.056,159.153,163.149,167.649,172.149,174.651,177.648,182.148,186.648,193.65,197.646,202.146,204.648,208.644,211.146,213.243,217.239,220.74,224.241,228.741,232.737,235.239,239.235,241.737,244.239,248.739,253.239,255.336,262.338,266.334,270.834,272.931,277.431,281.427,283.524,288.024,291.021,295.017" svgx:width="0.72,0.44,0.5,0.44,0.28,0.28,0.44,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.5,0.78,0.44,0.5,0.28,0.44,0.28,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.78,0.44,0.5,0.25,0.5,0.44,0.25,0.5,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Genetic and environmental association may be pre-</text>
   <text y="593.077" x="62.367,65.868,69.864,74.364,76.866,79.548,82.545,87.045,90.042,92.724,99.222,107.223,113.721,116.403,118.905,123.405,126.087,129.084,133.584,138.084,140.586,144.582,149.082,151.764,156.264,160.764,165.264,169.764,172.266,176.262,178.764,181.266,185.766,190.266,192.516,195.198,200.697,204.693,207.528,212.028,216.024,219.021,221.703,225.204,227.706,232.206,236.706,239.208,243.204,246.705,249.387,253.383,256.38,260.376,263.058,267.558,271.554,275.55,279.546,283.047,286.548,290.544,293.541,298.041" svgx:width="0.39,0.44,0.5,0.28,0.25,0.33,0.5,0.33,0.25,0.72,0.89,0.72,0.25,0.28,0.5,0.25,0.33,0.5,0.5,0.28,0.44,0.5,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.61,0.44,0.33,0.5,0.44,0.33,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.44,0.33,0.44,0.25,0.5,0.44,0.44,0.44,0.39,0.39,0.44,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sent for NMO in Indian population. Larger studies are necessary </text>
   <text y="604.075" x="62.367,64.869,69.369,71.619,74.616,78.612,83.112,85.614,88.116,92.112,96.108,98.61,102.606,104.856,107.358,111.858,115.854,119.355,123.351,125.601,130.101,133.098,137.094,139.596,142.098,149.1,151.602,156.102,160.098,163.095,167.595,169.845,172.842,175.344,179.844,184.344,186.846,191.346,195.846,199.347" svgx:width="0.28,0.5,0.25,0.33,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.39,0.44,0.25,0.5,0.33,0.44,0.28,0.28,0.78,0.28,0.5,0.44,0.33,0.5,0.25,0.33,0.28,0.5,0.5,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to replicate these preliminary findings.</text>
   <text y="637.078" x="62.367,67.866,72.366,76.866" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P636</text>
   <text y="648.076" x="62.367,68.37,73.374,77.37,79.62,82.122,87.126,91.122,95.118,99.114,103.614,107.115,111.111,113.361,117.861,120.858,123.108,129.606,136.104,140.604,145.104,147.354,152.358,154.86,159.36,164.364,166.614,173.112,180.114,182.364,186.36,190.356,192.858,195.36,198.861,201.111,205.611,210.615,215.619,217.869,222.369,226.365,229.362,231.864,236.364,240.864,243.861,247.857,252.861,255.111,261.114,265.11,269.106,273.606" svgx:width="0.67,0.56,0.44,0.25,0.28,0.56,0.44,0.44,0.44,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.72,0.72,0.5,0.5,0.25,0.56,0.28,0.5,0.56,0.25,0.72,0.78,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.5,0.56,0.56,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.33,0.44,0.56,0.25,0.67,0.44,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">The increase of CD56 high NK cells and activated Treg-</text>
   <text y="659.074" x="62.367,66.363,70.359,72.861,75.363,78.864,81.114,83.616,88.62,90.87,95.874,100.374,103.371,105.873,109.869,114.873,117.87,120.12,126.618,129.12,132.117,137.121,139.371,144.375,148.371,153.375,157.371,161.871,169.368,173.868,177.864,180.366,182.868,185.865,188.367,191.868,194.118,198.618,203.622,206.619,209.121,213.117,217.617,219.867,224.367,227.364,230.361,234.357,238.353,240.603,243.6,247.596,251.592,256.092,259.089,266.586,270.582,275.586,278.583" svgx:width="0.44,0.44,0.28,0.28,0.39,0.25,0.28,0.56,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.25,0.72,0.28,0.33,0.56,0.25,0.56,0.44,0.56,0.44,0.5,0.83,0.5,0.44,0.28,0.28,0.33,0.28,0.39,0.25,0.5,0.56,0.33,0.28,0.44,0.5,0.25,0.5,0.33,0.33,0.44,0.44,0.25,0.33,0.44,0.44,0.5,0.33,0.83,0.44,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">cells in patient with neuromyelitis optica after treatment </text>
   <text y="670.072" x="62.367,68.865,71.367,74.364,79.368,81.618,86.118,91.122,94.119,96.621,99.618,103.119,109.122,112.119,116.619,123.117,125.367,129.867,134.871,137.868,140.37,145.374,149.874,154.878,159.378,161.628,164.625,169.125,173.121,175.623,178.125,180.627,184.623,189.627,197.124,201.624" svgx:width="0.72,0.28,0.33,0.56,0.25,0.5,0.56,0.33,0.28,0.33,0.39,0.67,0.33,0.5,0.72,0.25,0.5,0.56,0.33,0.28,0.56,0.5,0.56,0.5,0.25,0.33,0.5,0.44,0.28,0.28,0.28,0.44,0.56,0.83,0.5,0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">with anti-IL-6R antibody tocilizumab</text>
   <text y="681.07" x="62.367,67.866,70.116,78.117,82.113,84.615,88.116,92.616,97.116,101.616" svgx:width="0.61,0.25,0.89,0.44,0.28,0.39,0.5,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">T Matsuoka</text>
   <text y="678.583" x="105.607" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="681.103" x="108.532,110.782,113.032,119.53,121.78,127.783,132.283,134.785,139.285" svgx:width="0.25,0.25,0.72,0.25,0.67,0.5,0.28,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Chiba</text>
   <text y="678.583" x="143.28" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="681.103" x="146.205,148.455,150.705,156.204,158.454,164.952,167.949,171.945,176.445,180.441,187.443" svgx:width="0.25,0.25,0.61,0.25,0.72,0.33,0.44,0.5,0.44,0.78,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T Aranami</text>
   <text y="678.583" x="189.945" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="681.103" x="192.87,195.12,197.37,205.371,207.621,214.119,218.115,222.615,226.611,233.613,238.113,241.11" svgx:width="0.25,0.25,0.89,0.25,0.72,0.44,0.5,0.44,0.78,0.5,0.33,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Nakamura</text>
   <text y="678.583" x="245.105" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="681.103" x="248.03,250.28,252.53,261.026,263.276,268.28,272.276,274.778" svgx:width="0.25,0.25,0.94,0.25,0.56,0.44,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, W Sato</text>
   <text y="678.583" x="279.278" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="681.103" x="282.203,284.453" svgx:width="0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="692.101" x="62.36,67.364,69.614,77.615,80.117,84.617,88.613,93.113" svgx:width="0.56,0.25,0.89,0.28,0.5,0.44,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">S Miyake</text>
   <text y="689.583" x="97.111" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="692.103" x="100.036,102.286,104.536,110.035,112.285,118.783,122.779,129.781,133.777,140.779,145.279,148.276" svgx:width="0.25,0.25,0.61,0.25,0.72,0.44,0.78,0.44,0.78,0.5,0.33,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T Yamamura</text>
   <text y="689.583" x="152.271" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="700.581" x="62.363" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="703.103" x="65.287,71.29,75.79,78.292,80.794,85.294,89.794,94.294,96.796,99.046,105.049,109.045,113.545,116.047,120.043,123.544,125.794,130.294,132.796,135.046,141.049,145.045,149.545,153.046,157.546,160.048,164.548,169.048,173.044,175.294,179.794,184.294,188.794,191.044,196.543,200.044,204.04,208.036,212.536,215.038,219.538,222.04,225.541,229.537,231.787,234.037,240.04,244.54,247.042,249.544,254.044,258.544,263.044,265.546" svgx:width="0.67,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.5,0.5,0.5,0.25,0.61,0.39,0.44,0.44,0.5,0.28,0.5,0.28,0.39,0.44,0.25,0.25,0.67,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">National Center of Neurology and Psychiatry, National </text>
   <text y="714.101" x="62.362,65.359,69.859,73.36,75.862,78.364,80.866,85.366,87.868,91.864,94.114,98.614,101.116,103.366,109.369,113.365,117.865,121.366,125.866,129.367,133.363,135.865,139.861,144.361,148.357,152.353,154.603,156.853,159.85,166.348,172.846,177.346,181.846,186.346,188.848,193.348,197.848,201.844,204.094,206.344,211.348,215.848,219.844,223.84,228.34,230.59,232.84,236.836,241.336,245.836,250.336,254.836,257.086" svgx:width="0.33,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.39,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.25,0.33,0.72,0.72,0.5,0.5,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.56,0.5,0.44,0.44,0.5,0.25,0.25,0.44,0.5,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Institute of Neuroscience, Immunology, Tokyo, Japan, </text>
   <text y="711.583" x="259.334" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="714.103" x="262.259,266.255,270.755,275.255,277.757,281.753,286.253,290.753,295.253" svgx:width="0.44,0.5,0.5,0.28,0.44,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Juntendo </text>
   <text y="725.101" x="62.36,68.858,73.358,75.86,79.856,83.852,87.353,90.854,93.356,95.858,99.854,102.104,106.604,110.6,115.1,119.6,124.1,126.602,128.852,133.352,135.854,138.104,145.601,149.597,154.097,156.599,160.595,163.097,167.597,171.593,173.843,176.093,179.09,185.588,192.086,196.586,201.086,205.586,208.088,212.588,217.088,221.084,223.334,225.584,230.588,235.088,239.084,243.08,247.58,249.83,252.08,256.076,260.576,265.076,269.576" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.44,0.5,0.5,0.5,0.28,0.25,0.5,0.28,0.25,0.83,0.44,0.5,0.28,0.44,0.28,0.5,0.44,0.25,0.25,0.33,0.72,0.72,0.5,0.5,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.56,0.5,0.44,0.44,0.5,0.25,0.25,0.44,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University School of Medicine, Immunology, Tokyo, Japan</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 446.300 L360.760 446.300 "/>
  <g begin="text">
   <text y="77.103" x="310.016,316.019,320.519,324.515,329.519,334.019,337.853,342.353,347.357,352.361,357.365,360.362" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="77.103" x="364.583,371.081,375.077,379.577,382.574,387.074,394.076,398.576,402.572,405.074,407.576,410.078,412.58,416.081,418.331,420.302,424.802,429.302,431.804,434.306,438.302,442.298,444.548,446.519,449.516,456.014,464.015,470.513,473.51,475.76,477.731,480.233,483.734,485.984,487.955,491.951,496.451,498.701,500.672,504.668,509.168,511.67,516.17,518.672,525.674,532.676,537.176,541.676,545.672" svgx:width="0.72,0.44,0.5,0.33,0.5,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.55,0.5,0.5,0.28,0.28,0.44,0.44,0.25,0.55,0.33,0.72,0.89,0.72,0.33,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.5,0.25,0.55,0.44,0.5,0.28,0.5,0.28,0.78,0.78,0.5,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Neuromyelitis optica (NMO) is an autoimmune </text>
   <text y="88.101" x="310.016,314.516,317.018,320.519,324.515,328.511,332.012,336.008,338.249,342.749,345.746,347.987,350.489,354.989,358.985,361.226,365.222,369.218,373.718,376.22,379.217,383.213,385.715,387.956,392.456,396.452,399.449,403.949,408.449,412.949,416.45,418.691,422.192,426.692,430.193,432.695,436.691,443.693,445.943,448.184,452.18,456.176,460.172,464.672,471.674,476.174,480.17,484.67,489.17,491.672,496.172,500.672,502.913,506.909,509.411,513.407,517.907,521.903,524.405,526.907,531.407,535.907,538.148,542.648,545.645" svgx:width="0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.25,0.5,0.44,0.33,0.5,0.5,0.5,0.39,0.25,0.39,0.5,0.39,0.28,0.44,0.78,0.25,0.25,0.44,0.44,0.44,0.5,0.78,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.25,0.44,0.28,0.44,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">disease of the central nervous system, accompanying elevation of </text>
   <text y="99.099" x="310.016,314.516,318.512,321.014,325.514,330.014,334.514,338.51,343.01,345.512,349.508,351.479,355.475,359.975,362.477,366.977,370.973,375.473,377.975,380.477,384.977,389.477,393.977,396.479,400.475,403.976,405.947,409.943,414.443,418.439,420.941,425.441,428.942,431.444,433.424,437.42,441.92,446.42,450.416,454.916,459.416,462.413,464.915,469.415,471.386,475.886,477.866,480.863,487.361,493.859,498.863,503.363,506.36,508.61,510.419,518.195,522.191,524.171,528.671,531.668,535.664,540.164,542.666" svgx:width="0.5,0.44,0.28,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.44,0.5,0.28,0.5,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.25,0.44,0.5,0.5,0.44,0.5,0.5,0.33,0.28,0.5,0.25,0.5,0.25,0.33,0.72,0.72,0.56,0.5,0.33,0.25,0.25,0.94,0.44,0.25,0.5,0.33,0.44,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pathogenic autoantibodies against aquaporin 4 (AQP4). We previ-</text>
   <text y="110.097" x="310.016,314.516,319.016,322.517,325.019,329.519,331.769,332.516,336.017,340.517,345.017,351.515,355.511,360.011,362.261,363.008,365.51,370.01,374.006,376.508,378.758,379.505,384.005,386.507,390.503,394.004,401.006,405.002,409.502,412.004,416.0,419.501,422.003,425.504,427.754,428.501,431.498,436.502,442.505,445.502,447.752,450.002,450.749,457.247,461.747,464.249,468.245,472.745,474.995,475.742,479.738,482.735,486.731,488.981,489.728,493.724,497.72,502.22,506.216,510.716,513.218,517.214,519.464,520.211,524.711,527.708,529.958,530.705,535.205,538.202,542.702" svgx:width="0.5,0.5,0.39,0.28,0.5,0.25,0.55,0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.5,0.28,0.44,0.39,0.78,0.44,0.5,0.28,0.44,0.39,0.28,0.39,0.25,0.55,0.33,0.56,0.67,0.33,0.25,0.25,0.55,0.72,0.5,0.28,0.44,0.5,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.44,0.44,0.5,0.44,0.5,0.28,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ously showed that plasmablasts (PB), which are capable of pro-</text>
   <text y="121.095" x="310.016,314.516,319.016,323.012,325.514,330.014,334.514,336.764,339.293,343.289,347.789,350.291,352.793,355.79,362.288,368.786,373.79,378.29,380.54,383.069,387.065,391.565,394.067,396.569,401.069,405.569,410.069,412.571,416.567,420.068,422.318,424.568,427.097,431.093,434.09,438.086,440.336,442.865,445.367,449.867,453.863,456.86,460.856,464.852,468.353,472.349,476.849,479.099,481.628,484.13,488.63,490.88,493.409,495.911,500.411,504.407,506.657,509.186,513.686,517.682,520.679,523.181,527.681,532.181,536.177,539.174,543.17,545.672" svgx:width="0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.72,0.72,0.56,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ducing anti-AQP4 antibodies, are increased in the peripheral </text>
   <text y="132.093" x="310.016,314.516,317.018,321.518,326.018,330.518,332.219,336.719,339.716,341.417,345.917,349.913,352.415,354.917,358.913,363.413,365.915,369.416,371.117,377.615,380.117,382.619,387.119,388.82,395.318,403.319,409.817,412.067,413.768,417.764,422.264,426.764,428.465,430.967,435.467,439.463,441.965,443.666,446.168,450.668,454.664,456.365,459.866,464.366,467.363,471.863,474.365,478.865,482.861,485.363,487.064,491.564,494.561,496.262,501.266,507.269,508.97,511.472,514.973,516.674,521.174,525.17,529.67,533.666,538.166,542.666" svgx:width="0.5,0.28,0.5,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.89,0.72,0.25,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.28,0.25,0.28,0.5,0.44,0.25,0.39,0.5,0.33,0.5,0.28,0.5,0.44,0.28,0.25,0.5,0.33,0.25,0.56,0.67,0.25,0.28,0.39,0.25,0.5,0.44,0.5,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">blood of patients with NMO, and that the survival of PB is depend-</text>
   <text y="143.091" x="310.016,314.012,318.512,321.014,323.264,325.397,329.897,334.397,336.647,338.78,341.777,347.276,350.273,354.773,357.023,359.156,362.153,366.149,370.145,374.141,378.641,381.143,385.643,388.64,390.89,393.023,396.02,399.017,404.516,407.513,412.013,418.016,421.013,423.263,425.396,428.897,431.399,435.899,440.399,444.395,446.897,449.399,453.899,458.399,460.649,462.782,465.779,471.782,476.282,478.784,483.284,487.28,490.277,494.273,496.523,498.656,502.652,505.154,507.404,509.537,513.533,516.035,518.285,520.535,522.668,527.672,534.17,540.668,545.672" svgx:width="0.44,0.5,0.28,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.61,0.33,0.5,0.25,0.55,0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.25,0.55,0.33,0.33,0.61,0.33,0.5,0.67,0.33,0.25,0.55,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.67,0.5,0.28,0.5,0.44,0.33,0.44,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.55,0.56,0.72,0.72,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ent on IL-6 receptor (IL-6R) signaling (Chihara et al. PNAS </text>
   <text y="154.089" x="310.016,314.516,319.016,323.183,327.683,330.68,332.93,335.423,340.922,345.422,349.418,352.415,356.411,359.408,363.908,366.905,370.901,373.151,375.806,382.304,386.3,388.955,392.951,397.451,401.951,406.451,410.951,414.947,417.449,421.445,425.945,428.6,432.596,437.096,439.751,443.747,448.247,452.747,455.249,459.749,462.746,466.742,469.244,473.744,476.741,481.241,483.896,487.397,489.899,494.399,498.899,503.399,506.054,508.556,513.056,515.711,519.707,524.207,528.203,530.705,535.205,539.201,541.703,545.699" svgx:width="0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.61,0.5,0.44,0.33,0.44,0.33,0.5,0.33,0.44,0.25,0.25,0.72,0.44,0.25,0.44,0.5,0.5,0.5,0.5,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.25,0.44,0.5,0.5,0.28,0.5,0.33,0.44,0.28,0.5,0.33,0.5,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">2011). Therefore, we conducted an exploratory study to evaluate </text>
   <text y="165.087" x="310.016,312.518,317.018,321.014,323.921,327.422,331.418,334.415,338.411,340.913,345.413,348.311,352.307,356.807,361.307,364.205,368.201,371.036,374.033,376.535,380.531,384.527,388.523,393.023,395.921,400.421,403.418,406.325,408.827,413.327,417.323,419.825,422.327,424.829,428.825,433.325,440.327,444.323,448.823,451.73,454.727,460.226,466.229,471.728,474.725,476.975,479.873,483.869,486.776,491.276,495.776,502.778,506.774,511.274,513.776,517.772,521.768,526.268,529.166,533.162,537.662,540.164,542.666" svgx:width="0.28,0.5,0.44,0.25,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.28,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.33,0.61,0.67,0.61,0.33,0.25,0.25,0.44,0.25,0.5,0.5,0.78,0.44,0.5,0.28,0.44,0.44,0.5,0.25,0.44,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the safety and efficacy of tocilizumab (TCZ), a humanized anti-</text>
   <text y="176.085" x="310.016,313.013,318.512,321.509,326.009,332.012,334.262,335.441,342.443,346.943,351.443,355.943,359.939,362.441,366.941,371.441,375.437,377.939,380.189,381.368,385.364,389.864,392.366,394.868,399.368,403.868,408.368,412.283,414.533,416.783,417.962,420.464,424.964,427.214,428.393,434.891,442.892,449.39,451.64,453.89,455.069,459.065,463.565,468.065,470.315,471.494,475.49,479.99,484.49,487.487,489.989,492.986,499.988,503.984,508.484,510.734,511.913,514.415,518.915,522.911,525.413,527.663,528.68,534.179,540.182,545.681" svgx:width="0.33,0.61,0.33,0.5,0.67,0.25,0.55,0.78,0.5,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.89,0.72,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.33,0.28,0.33,0.78,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.61,0.67,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">IL-6R monoclonal antibody, in NMO, and confirmed that TCZ </text>
   <text y="187.083" x="310.016,312.518,315.515,319.511,323.507,326.009,333.011,337.007,341.507,344.009,346.196,349.697,352.199,356.699,361.199,363.701,366.698,369.2,373.196,377.192,381.692,384.194,386.696,391.196,393.383,396.38,400.376,404.876,409.376,413.372,417.368,421.868,424.055,428.051,432.551,437.051,441.551,445.547,448.049,450.551,454.547,458.543,463.043,465.23,468.227,472.223,474.725,478.721,483.221,486.722,490.718,492.896,495.893,499.889,502.391,506.387,508.637,510.824,514.82,518.321,520.508,527.006,531.002,533.504,536.006,538.193,542.189,545.69" svgx:width="0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.33,0.44,0.5,0.5,0.44,0.44,0.5,0.25,0.44,0.5,0.5,0.5,0.44,0.28,0.28,0.44,0.44,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.33,0.44,0.28,0.44,0.25,0.25,0.44,0.39,0.25,0.72,0.44,0.28,0.28,0.25,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treatment significantly reduced annualized relapse rate, as well as </text>
   <text y="198.081" x="310.016,314.561,318.602,323.147,326.189,330.734,335.279,339.32,343.865,346.412,350.453,353.108,357.653,361.694,364.241,368.786,371.441,375.482,380.027,384.572,387.227,390.269,394.31,396.857,399.404,403.949,408.494,412.535,415.19,417.737,422.282,424.937,428.483,432.524,437.069,441.11,445.655,448.31,452.855,456.896,459.443,461.99,466.031,470.576,473.123,476.669,479.324,485.867,488.414,490.961,495.506,498.161,504.704,512.75,519.293,521.948,524.99,531.533,534.575,538.616,543.161,545.663,545.672" svgx:width="0.5,0.44,0.5,0.33,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.5,0.44,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.33,0.44,0.28,0.28,0.5,0.5,0.44,0.25,0.28,0.5,0.25,0.39,0.44,0.5,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.89,0.72,0.25,0.33,0.72,0.33,0.44,0.5,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">neurogenic pain and fatigue in seven patients with NMO (Araki </text>
   <text y="209.079" x="310.016,314.012,316.514,318.764,319.718,323.714,326.216,328.466,330.716,331.67,338.168,342.164,346.664,349.661,354.161,356.663,361.163,365.663,370.163,372.413,373.367,377.867,382.367,386.867,391.367,394.364,396.614,398.864,399.656,407.432,411.428,413.678,414.632,418.628,421.13,424.631,429.131,431.381,432.335,436.331,440.831,445.331,448.328,450.83,453.827,460.829,464.825,469.325,471.575,472.529,475.031,479.531,483.527,485.777,486.731,489.728,493.724,498.224,502.724,506.72,509.222,511.724,516.224,520.724,522.974,523.928,528.428,531.425,533.675,534.629,539.633,545.636" svgx:width="0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.55,0.72,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.94,0.44,0.25,0.55,0.44,0.28,0.39,0.5,0.25,0.55,0.44,0.5,0.5,0.33,0.28,0.33,0.78,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.33,0.44,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.56,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">et al. Neurology 2014). We also confirmed the reduction of PB </text>
   <text y="220.077" x="310.016,314.516,319.016,326.018,330.518,334.514,337.511,341.012,343.262,344.081,347.078,351.578,354.08,356.582,361.082,367.58,370.082,374.582,379.082,381.332,382.151,384.653,389.153,391.655,395.651,399.647,402.149,404.651,409.151,413.651,415.901,416.72,421.22,424.217,427.124,432.623,438.626,444.125,446.375,447.194,449.696,454.196,456.446,457.265,459.767,466.265,470.765,473.015,473.834,478.334,482.33,484.832,487.334,491.33,495.83,498.332,501.833,504.083,506.333,507.152,510.653,515.153,519.653,524.153,528.149,531.65,534.152,536.654,541.154,545.654" svgx:width="0.5,0.5,0.78,0.5,0.44,0.33,0.39,0.25,0.55,0.33,0.5,0.28,0.28,0.5,0.72,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.61,0.67,0.61,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.72,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">numbers following injection of TCZ in two patients, suggesting </text>
   <text y="231.075" x="310.016,312.518,317.018,321.014,323.516,325.766,330.77,336.773,339.023,343.019,347.519,352.019,354.521,359.021,361.271,365.771,369.767,372.017,376.517,381.017,385.013,387.263,391.763,394.76,397.01,399.512,404.012,408.008,410.258,412.76,416.756,419.591,424.091,428.087,430.589,434.09,436.34,440.84,443.837,445.925,451.424,457.427,462.926,465.176" svgx:width="0.28,0.5,0.44,0.28,0.25,0.56,0.67,0.25,0.44,0.5,0.5,0.28,0.5,0.25,0.5,0.44,0.25,0.5,0.5,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.44,0.33,0.5,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.61,0.67,0.61,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">that PB could be one of the targets of TCZ .</text>
   <text y="242.073" x="310.016,317.018,322.022,325.019,329.015,333.011,336.008,338.51,343.01,347.006,350.507,353.504" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="242.073" x="356.141,362.639,367.139,373.637,377.633,382.133,386.129,388.766,391.016,393.653,397.649,402.149,406.649,411.149,415.649,419.645,424.145,428.645,433.145,436.646,439.283,442.28,447.779,450.776,455.276,457.913,464.915,468.911,473.411,476.048,478.55,483.05,486.047,488.549,493.049,497.045,501.545,505.541,509.537,512.174,515.171,519.671,524.171,528.167,530.669,533.171,537.671,542.171,545.672" svgx:width="0.72,0.5,0.72,0.44,0.5,0.44,0.33,0.25,0.25,0.44,0.5,0.5,0.5,0.5,0.44,0.5,0.5,0.5,0.39,0.25,0.33,0.61,0.33,0.5,0.25,0.78,0.44,0.5,0.25,0.28,0.5,0.33,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">However, endogenous IL-6 may influence functions </text>
   <text y="253.071" x="310.016,314.516,317.513,319.97,324.47,326.972,331.472,335.468,338.465,340.922,343.424,350.426,357.428,361.928,366.428,370.424,372.881,376.877,380.873,383.375,385.877,389.378,391.628,394.085,397.586,402.086,406.082,410.582,413.039,417.035,420.536,422.831,428.168,430.625,434.621,438.617,441.119,443.621,447.122,449.579,453.575,458.075,462.575,465.032,472.034,476.534,480.53,483.032,487.532,490.034,494.534,496.991,500.987,504.983,507.485,509.987,513.488,515.738,518.195,522.695,525.197,528.194,532.19,536.186,538.688,541.19,545.69" svgx:width="0.5,0.33,0.25,0.5,0.28,0.5,0.44,0.33,0.25,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.39,0.5,0.44,0.5,0.25,0.44,0.39,0.25,0.61,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.78,0.5,0.44,0.28,0.5,0.28,0.5,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.5,0.28,0.33,0.44,0.44,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of other immune cells, such as T cells and myeloid cells, directly </text>
   <text y="264.069" x="310.016,314.516,317.513,320.015,322.517,327.017,331.517,334.019,337.016,341.012,345.008,347.51,350.012,353.927,356.177,358.679,365.177,369.677,372.179,376.175,380.675,383.177,390.179,394.175,398.675,401.177,403.679,407.675,411.671,416.171,418.673,421.175,425.675,428.177,432.677,437.177,440.678,443.675,447.671,452.171,456.671,459.173,463.169,465.671,469.667,474.167,476.669,479.171,486.173,493.175,497.675,502.175,506.171,508.673,513.173,517.169,519.671,523.667,528.167,532.163,536.159,538.661,541.163,545.663" svgx:width="0.5,0.33,0.25,0.28,0.5,0.5,0.28,0.33,0.44,0.44,0.28,0.28,0.5,0.25,0.25,0.72,0.5,0.28,0.44,0.5,0.25,0.78,0.44,0.5,0.25,0.28,0.44,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.39,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.5,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">or indirectly, which may lead to dysregulated immune balance in </text>
   <text y="275.067" x="310.016,316.514,324.515,331.013" svgx:width="0.72,0.89,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NMO.</text>
   <text y="286.065" x="310.016,318.512,322.508,325.505,330.509,335.009,340.013,343.514,346.511" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="286.065" x="348.41,353.279,357.779,359.678,363.674,368.174,372.674,375.671,379.667,383.168,386.669,388.568,391.07,395.57,398.072,401.573,403.472,405.974,409.475,412.976,417.476,421.472,423.722,425.621,432.119,436.115,438.014,445.016,449.012,453.512,457.508,459.407,466.409,470.909,475.409,477.911,482.411,484.913,489.413,491.312,494.309,496.811,501.311,507.809,509.708,513.704,518.204,520.706,525.206,532.208,536.204,538.706,542.702,545.699" svgx:width="0.61,0.5,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.25,0.28,0.5,0.28,0.39,0.25,0.28,0.39,0.39,0.5,0.44,0.25,0.25,0.72,0.44,0.25,0.78,0.44,0.5,0.44,0.25,0.78,0.5,0.5,0.28,0.5,0.28,0.5,0.25,0.33,0.28,0.5,0.72,0.25,0.44,0.5,0.28,0.5,0.78,0.44,0.28,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To address this issue, we made monthly flow cytometer </text>
   <text y="297.063" x="310.016,314.012,318.512,322.508,325.01,329.51,333.011,335.513,339.014,341.264,343.181,347.681,350.678,352.928,354.845,359.345,363.341,366.338,368.84,373.34,377.84,381.836,384.833,388.829,391.331,393.581,395.498,399.998,402.5,407.0,411.5,416.0,418.25,420.167,422.669,427.169,434.171,438.671,443.171,447.671,451.667,456.167,458.669,462.665,464.915,466.832,470.333,474.833,479.333,482.834,486.83,489.332,492.833,495.083,497.0,501.5,505.496,508.493,510.995,515.495,519.491,523.991,526.241,528.158,531.155,534.152,538.652,545.654" svgx:width="0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.44,0.28,0.25,0.55,0.5,0.28,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.55,0.39,0.5,0.5,0.39,0.44,0.28,0.39,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.55,0.33,0.33,0.5,0.78,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">analysis of peripheral blood lymphocyte subsets derived from </text>
   <text y="308.061" x="310.016,316.514,324.515,331.013,333.263,337.763,341.759,344.261,346.763,350.759,355.259,357.761,361.262,363.512,370.01,374.51,379.01,381.26,385.76,389.756,392.753,395.255,397.757,401.753,404.255,408.755,412.751,415.253,419.249,423.749,425.999,428.501,433.001,435.251,437.753,442.253,446.249,448.499,452.495,456.995,461.495,463.997,468.497,471.494,475.49,477.992,482.492,485.489,489.989,492.239,495.74,498.242,502.742,507.242,511.157" svgx:width="0.72,0.89,0.72,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.5,0.5,0.25,0.5,0.44,0.33,0.28,0.28,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.28,0.5,0.33,0.44,0.28,0.5,0.33,0.5,0.25,0.39,0.28,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NMO patients who participated in the exploratory study.</text>
   <text y="319.059" x="310.016,316.514,320.51,324.011,329.015,331.517,334.514,338.015,341.012" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="319.059" x="343.721,350.219,354.215,357.212,361.208,363.458,366.167,372.665,376.661,379.37,382.367,386.363,390.863,395.363,398.36,400.862,403.571,406.073,410.573,414.569,417.071,419.78,422.282,426.782,430.778,433.325,438.824,444.827,450.326,453.035,455.537,458.534,462.53,466.526,469.028,476.03,480.026,484.526,487.028,489.737,496.235,500.735,505.235,507.737,512.237,514.946,517.448,521.948,526.448,530.948,534.944,538.94,541.649,545.645" svgx:width="0.72,0.44,0.33,0.44,0.25,0.25,0.72,0.44,0.25,0.33,0.44,0.5,0.5,0.33,0.28,0.25,0.28,0.5,0.44,0.28,0.25,0.28,0.5,0.44,0.25,0.61,0.67,0.61,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.72,0.5,0.5,0.28,0.5,0.25,0.28,0.5,0.5,0.5,0.44,0.44,0.25,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Here, we report that the TCZ treatment would induce a </text>
   <text y="330.057" x="310.016,313.517,316.019,320.519,325.019,327.521,330.518,333.02,337.016,341.012,345.512,348.014,350.264,351.353,355.349,359.849,364.349,366.599,367.688,371.684,376.184,380.684,383.186,385.688,390.188,394.688,399.188,403.688,407.189,409.439,410.528,413.03,417.53,421.526,424.523,428.519,432.515,436.016,440.012,442.262,443.351,447.851,450.848,453.098,454.187,460.19,466.688,471.188,475.688,477.938,479.027,483.527,486.029,490.529,495.029,497.279,498.368,502.868,506.864,509.366,513.866,516.863,520.859,523.361,525.611,526.7,531.2,533.702,536.204,538.706,542.702,545.699" svgx:width="0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.39,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.67,0.72,0.5,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.5,0.33,0.44,0.28,0.25,0.55,0.5,0.28,0.28,0.28,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">significant and continuous increase of CD56 high natural killer </text>
   <text y="341.055" x="310.016,314.012,318.008,320.51,323.012,326.513,328.664,332.66,337.16,341.66,343.811,348.311,351.308,353.459,358.463,362.963,367.463,371.963,376.463,378.614,383.114,387.614,391.115,393.617,396.119,398.621,403.121,407.117,409.268,413.264,417.26,419.762,422.264,426.764,430.76,433.262,437.258,441.758,443.909,446.906,450.902,455.402,459.902,462.404,466.4,468.902,473.402,476.399,480.899,482.888,488.225,490.376,494.372,498.368,500.87,503.372,506.873,509.024,513.524,518.024,521.021,523.523,528.023,532.523,534.674,537.176,541.676,545.672" svgx:width="0.44,0.44,0.28,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.5,0.33,0.25,0.56,0.5,0.5,0.5,0.5,0.25,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.61,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cells and of Foxp3 positive activated regulatory T cells during the </text>
   <text y="352.053" x="310.016,313.013,315.515,318.512,322.013,324.515,326.765,331.265,335.261,339.257,342.254,344.504,349.004,352.001,354.089,359.588,365.591,371.09,373.34,375.842,378.839,382.835,386.831,389.333,396.335,400.331,404.831,407.333" svgx:width="0.33,0.28,0.33,0.39,0.28,0.25,0.5,0.44,0.44,0.33,0.25,0.5,0.33,0.25,0.61,0.67,0.61,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">first year of TCZ treatment.</text>
   <text y="363.051" x="310.016,316.514,321.014,326.018,330.014,332.516,337.52,341.021,343.523,348.023,353.027,356.528,359.525" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="363.051" x="362.342,367.841,372.341,376.841,380.342,382.592,385.409,389.405,393.905,396.902,399.899,403.895,407.891,410.393,412.895,417.395,421.895,424.712,429.212,432.209,435.026,439.526,444.026,447.527,450.524,454.52,459.02,463.52,466.022,470.018,472.52,476.516,481.016,483.833,486.335,493.337,500.339,504.839,509.339,513.335,516.152,520.652,524.648,527.15,533.648,538.148,541.145,545.645" svgx:width="0.61,0.5,0.5,0.39,0.25,0.25,0.44,0.5,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.5,0.39,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.5,0.44,0.28,0.72,0.5,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Thus, correction of dysregulated immune network </text>
   <text y="374.049" x="310.016,314.012,318.512,323.012,325.514,330.014,331.913,336.413,340.409,342.308,346.808,351.308,355.304,357.203,361.703,364.7,366.599,369.101,373.601,377.597,379.496,386.498,390.494,394.49,398.99,402.986,407.486,409.988,413.489,420.491,423.992,425.891,430.391,434.891,436.79,443.288,447.788,450.29,454.286,458.786,460.523,466.022,472.025,477.524,479.423,485.921,490.421,494.921,497.423,501.923,503.822,506.819,510.815,515.315,519.815,522.317,526.313,528.815,532.811,534.71,537.212,541.712,545.708" svgx:width="0.44,0.5,0.5,0.28,0.5,0.25,0.5,0.44,0.25,0.5,0.5,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.78,0.44,0.44,0.5,0.44,0.5,0.28,0.39,0.78,0.39,0.25,0.5,0.5,0.25,0.72,0.5,0.28,0.44,0.5,0.25,0.61,0.67,0.61,0.25,0.72,0.5,0.5,0.28,0.5,0.25,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">could be one of the mechanisms by which TCZ would regulate the </text>
   <text y="385.047" x="310.016,314.516,317.018,320.519,324.515,328.511,332.012,336.008,338.258,342.254,346.25,348.752,351.254,355.754,358.256,360.758,365.258,367.508,372.008,375.005,377.255,383.753,391.754,398.252" svgx:width="0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.72,0.89,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">disease activity of NMO.</text>
   <text y="412.047" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P637</text>
   <text y="423.045" x="310.016,316.019,320.519,325.019,327.521,332.525,337.025,340.022,342.524,347.024,352.028,354.278,358.778,361.775,364.025,367.022,371.018,375.014,379.514,382.511,390.008,394.004,399.008,402.005,404.255,408.251,412.247,415.748,420.752,425.252,430.256,433.757,437.753,440.003,443.0,447.5,449.75,454.754,457.256,461.756,465.257,472.754,477.254,482.258,487.262,491.258,495.254,499.25,502.751,505.253,508.754,511.004,513.506,518.51" svgx:width="0.67,0.5,0.5,0.28,0.56,0.5,0.33,0.28,0.5,0.56,0.25,0.5,0.33,0.25,0.33,0.44,0.44,0.5,0.33,0.83,0.44,0.56,0.33,0.25,0.44,0.44,0.39,0.56,0.5,0.56,0.39,0.44,0.25,0.33,0.5,0.25,0.56,0.28,0.5,0.39,0.83,0.5,0.56,0.56,0.44,0.44,0.44,0.39,0.28,0.39,0.25,0.28,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Evaluation of treatment response to plasmapheresis in </text>
   <text y="434.043" x="310.016,314.516,318.512,323.516,326.513,330.509,332.759,336.755,341.255,345.755,349.751,353.747,357.743,362.747,367.247,370.244,372.746,377.246,382.25,385.751,388.001,392.501,395.498,397.748,402.752,406.748,411.752,415.748,420.248,427.745,432.245,436.241,438.743,441.245,444.242,446.744,450.245,452.495,456.995,461.999,464.996,467.498,471.494" svgx:width="0.5,0.44,0.56,0.33,0.44,0.25,0.44,0.5,0.5,0.44,0.44,0.44,0.56,0.5,0.33,0.28,0.5,0.56,0.39,0.25,0.5,0.33,0.25,0.56,0.44,0.56,0.44,0.5,0.83,0.5,0.44,0.28,0.28,0.33,0.28,0.39,0.25,0.5,0.56,0.33,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">acute exacerbations of neuromyelitis optica</text>
   <text y="445.041" x="310.016,316.514,322.013,327.017,329.267,334.766,337.268,341.768,346.268,350.264,353.261,357.257" svgx:width="0.72,0.61,0.56,0.25,0.61,0.28,0.5,0.5,0.44,0.33,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">GES Linhares</text>
   <text y="442.583" x="360.757" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="445.103" x="363.682,365.932,368.182,373.186,378.685,385.183,387.433,392.437,396.433,399.43,403.426,405.928,408.925" svgx:width="0.25,0.25,0.56,0.61,0.72,0.25,0.56,0.44,0.33,0.44,0.28,0.33,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, SLA Pereira</text>
   <text y="442.583" x="412.92" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="445.103" x="415.845,418.095,420.345,425.349,433.35,439.848,442.098,445.599,450.099,453.096,457.596" svgx:width="0.25,0.25,0.56,0.89,0.72,0.25,0.39,0.5,0.33,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, FMH Jorge</text>
   <text y="442.583" x="461.592" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="445.103" x="464.517,466.767,469.017,475.02,477.27,482.274,484.776,491.778" svgx:width="0.25,0.25,0.67,0.25,0.56,0.28,0.78,0.78" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, R Simm</text>
   <text y="442.583" x="498.78" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="445.103" x="501.705,503.955,506.205,511.704,519.705" svgx:width="0.25,0.25,0.61,0.89,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, LM </text>
   <text y="456.101" x="310.014,316.512,319.014,321.516,326.016,330.012,332.514,335.511" svgx:width="0.72,0.28,0.28,0.5,0.44,0.28,0.33,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Oliveira</text>
   <text y="453.583" x="339.508" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="456.103" x="342.433,344.683,346.933,352.432,357.436,359.686,367.687,371.683,376.183,380.683,384.679" svgx:width="0.25,0.25,0.61,0.56,0.25,0.89,0.44,0.5,0.5,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, LS Mendes</text>
   <text y="453.583" x="388.18" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="456.103" x="391.105,393.355,395.605,402.103,404.353,410.356,414.352,416.854,419.356,423.352,427.852,431.848,434.845" svgx:width="0.25,0.25,0.72,0.25,0.67,0.44,0.28,0.28,0.44,0.5,0.44,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D Callegaro</text>
   <text y="453.583" x="439.344" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="464.581" x="310.018" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="467.103" x="312.941,319.439,323.939,326.441,330.437,334.433,337.934,341.435,343.937,346.439,350.435,352.685,357.185,359.687,361.937,366.437,370.937,375.437,377.687,383.186,387.686,392.186,394.688,399.188,401.438,403.688,409.691,413.687,418.187,421.688,426.188,428.69,433.19,437.69,441.686,443.936,446.186,450.686,455.186,459.686,461.936,467.435,471.935,476.435,478.937,483.437,485.687,487.937,493.436,496.937,501.437,504.938,507.44" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.5,0.5,0.5,0.25,0.61,0.5,0.5,0.28,0.5,0.25,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.5,0.5,0.5,0.25,0.61,0.5,0.5,0.28,0.5,0.25,0.25,0.61,0.39,0.5,0.39,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Sao Paulo, Neurology, São Paulo, Brazil</text>
   <text y="494.103" x="310.016,316.019,320.519,324.515,329.519,334.019,337.853,342.353,347.357,352.361,357.365,360.362" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="494.103" x="363.053,369.551,373.547,378.047,381.044,385.544,392.546,397.046,401.042,403.544,406.046,408.548,411.05,414.551,417.242,421.742,426.242,428.744,431.246,435.242,439.238,441.929,444.431,447.932,450.623,454.619,459.119,461.81,465.806,470.306,472.808,477.308,479.81,486.812,493.814,498.314,502.814,506.81,509.501,514.001,516.503,520.004,524.0,527.996,531.497,535.493,538.184,542.684,545.681" svgx:width="0.72,0.44,0.5,0.33,0.5,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.5,0.5,0.28,0.28,0.44,0.44,0.25,0.28,0.39,0.25,0.44,0.5,0.25,0.44,0.5,0.28,0.5,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Neuromyelitis optica is an autoimmune disease of </text>
   <text y="505.101" x="310.016,312.518,317.018,321.014,323.165,327.161,331.157,335.657,338.159,341.156,345.152,347.654,349.805,354.305,358.301,361.298,365.798,370.298,374.798,378.299,380.45,383.951,388.451,391.952,394.454,398.45,405.452,407.603,410.105,414.605,418.601,421.103,423.254,427.754,430.751,434.747,438.248,442.244,446.744,449.246,452.747,454.898,459.398,462.395,466.391,470.891,475.391,482.393,484.895,489.395,493.391,497.891,500.393,502.895,507.395,509.537,516.035,518.537,521.039,525.539,527.69,532.19,536.69,539.192,541.694,545.69" svgx:width="0.28,0.5,0.44,0.25,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.25,0.5,0.44,0.33,0.5,0.5,0.5,0.39,0.25,0.39,0.5,0.39,0.28,0.44,0.78,0.25,0.28,0.5,0.44,0.28,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.39,0.25,0.5,0.33,0.44,0.5,0.5,0.78,0.28,0.5,0.44,0.5,0.28,0.28,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.5,0.28,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the central nervous system that presents predominantly with optic </text>
   <text y="516.099" x="310.016,314.516,318.512,323.012,326.009,328.511,331.013,333.515,337.016,339.527,342.524,349.022,355.52,358.517,361.028,365.024,369.524,374.024,376.535,383.537,388.037,392.033,394.535,397.037,399.539,402.041,405.542,407.792,410.141,415.64,420.14,424.136,426.647,430.643,434.144,437.645,442.145,446.141,448.643,452.639,455.141,457.643,462.143,466.643,469.154,473.654,476.651,479.162,481.664,486.164,490.16,492.671,495.668,500.168,506.666,509.177,513.173,515.675,519.671,523.172,526.673,529.184,533.18,537.68,540.182,542.684" svgx:width="0.5,0.44,0.5,0.33,0.28,0.28,0.28,0.39,0.25,0.33,0.72,0.72,0.33,0.25,0.44,0.5,0.5,0.25,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.25,0.61,0.5,0.44,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.33,0.5,0.72,0.25,0.44,0.28,0.44,0.39,0.39,0.25,0.44,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">neuritis (ON) and myelitis. The association of the IgG class anti-</text>
   <text y="527.097" x="310.016,314.516,319.016,323.516,326.018,330.014,333.515,335.765,338.465,342.965,345.467,348.464,352.46,356.456,358.958,362.954,367.454,369.704,372.404,376.4,380.9,384.896,387.398,391.898,395.399,397.901,400.151,402.851,405.353,409.853,413.849,416.099,418.799,422.795,427.295,431.795,435.791,440.291,444.791,447.788,450.29,454.79,457.787,462.287,464.537,467.237,471.233,475.733,479.729,484.229,488.729,492.725,495.227,497.477,500.177,503.174,509.672,516.17,521.174,525.674,528.671,531.668,536.168,542.666,545.663" svgx:width="0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.44,0.5,0.5,0.33,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.5,0.44,0.5,0.5,0.44,0.28,0.25,0.55,0.33,0.72,0.72,0.56,0.5,0.33,0.33,0.5,0.72,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">bodies directed against the aquaporin-4 channel (AQP4-IgG) </text>
   <text y="538.095" x="310.016,314.012,316.514,319.016,323.516,330.014,333.515,336.332,340.328,344.324,347.321,349.823,354.323,357.14,361.64,364.142,368.138,372.638,377.138,381.638,385.139,387.641,391.142,393.959,398.459,401.456,404.273,406.775,409.277,416.279,418.781,421.283,425.279,429.779,432.596,435.593,440.093,443.09,450.092,453.593,455.843,458.66,462.161,466.661,470.657,475.157,477.974,481.97,485.471,488.288,494.786,501.284,504.101,508.601,511.598,514.415,521.417,525.917,529.913,532.415,534.917,537.419,539.921,543.422,545.672" svgx:width="0.44,0.28,0.28,0.5,0.72,0.39,0.25,0.44,0.44,0.33,0.28,0.5,0.25,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.39,0.25,0.5,0.33,0.25,0.28,0.28,0.78,0.28,0.28,0.44,0.5,0.25,0.33,0.5,0.33,0.78,0.39,0.25,0.25,0.39,0.5,0.44,0.5,0.25,0.44,0.39,0.25,0.72,0.72,0.25,0.5,0.33,0.25,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">allows early diagnosis of limited forms, such as ON or myelitis, </text>
   <text y="549.093" x="310.016,314.012,318.512,323.012,326.513,329.015,333.515,337.511,340.508,344.504,349.004,351.254,352.622,357.122,361.118,364.115,366.617,368.867,370.235,374.735,377.732,379.982,381.35,383.852,388.352,392.348,394.598,395.966,399.467,403.967,407.963,411.959,414.461,417.458,421.958,428.96,431.21,432.578,437.078,440.075,442.325,443.693,450.191,458.192,464.69,466.94,468.308,472.808,475.31,478.811,483.311,486.308,490.808,494.804,497.801,501.302,503.552,504.92,507.917,514.415,522.416,528.914,533.918,540.416,543.413,545.663" svgx:width="0.44,0.5,0.5,0.39,0.28,0.5,0.44,0.33,0.44,0.5,0.25,0.55,0.5,0.44,0.33,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.5,0.44,0.44,0.28,0.33,0.5,0.78,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.89,0.72,0.25,0.55,0.5,0.28,0.39,0.5,0.33,0.5,0.44,0.33,0.39,0.25,0.55,0.33,0.72,0.89,0.72,0.56,0.72,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">considered part of the spectrum of NMO disorders (NMOSD). </text>
   <text y="560.091" x="310.016,316.514,320.51,325.01,327.512,331.508,333.758,335.918,339.914,344.414,348.41,352.406,356.402,359.399,363.899,367.895,370.397,372.899,377.399,381.899,385.4,387.65,389.81,393.806,396.803,400.799,403.049,405.209,407.711,410.708,414.704,418.7,421.202,425.198,429.698,431.948,434.108,440.606,443.108,445.61,450.11,452.36,454.52,461.522,465.518,468.02,472.52,477.02,479.522,484.022,487.019,491.015,495.515,500.015,502.517,506.018,510.518,513.02,517.52,522.02,526.016,528.266,530.516,532.676,535.673,540.173,542.675" svgx:width="0.72,0.44,0.5,0.28,0.44,0.25,0.55,0.44,0.5,0.44,0.44,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.78,0.44,0.28,0.5,0.5,0.28,0.5,0.33,0.44,0.5,0.5,0.28,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.55,0.33,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Acute exacerbations are treated with methylprednisolone, fol-</text>
   <text y="571.089" x="310.016,312.518,317.018,323.516,327.512,332.012,334.865,339.365,343.865,346.718,351.218,353.72,357.716,361.217,368.219,372.215,376.715,381.215,385.211,388.208,392.204,395.705,398.207,401.708,404.561,407.063,411.563,414.416,417.413,421.409,424.406,427.403,431.399,435.395,437.897,442.397,445.394,449.894,452.747,457.247,461.243,463.745,466.247,470.243,474.743,477.245,480.746,482.996,485.354,491.852,498.35,503.354,507.854,510.851,513.848,518.348,524.846,527.699,531.2,535.196,538.193,542.693" svgx:width="0.28,0.5,0.72,0.44,0.5,0.25,0.5,0.5,0.25,0.5,0.28,0.44,0.39,0.78,0.44,0.5,0.5,0.44,0.33,0.44,0.39,0.28,0.39,0.25,0.28,0.5,0.25,0.33,0.44,0.33,0.33,0.44,0.44,0.28,0.5,0.33,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.72,0.72,0.56,0.5,0.33,0.33,0.5,0.72,0.25,0.39,0.44,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lowed by plasmapheresis in refractory patients. AQP4-IgG sero-</text>
   <text y="582.087" x="310.016,314.516,319.016,322.517,325.019,327.521,330.023,334.523,337.025,339.527,344.027,345.971,349.472,353.972,358.472,362.972,367.472,370.469,372.971,376.472,378.416,380.918,385.418,389.414,391.358,395.858,399.359,403.355,405.299,409.799,412.796,414.74,417.242,421.742,425.738,428.735,432.731,437.231,441.731,443.675,448.175,452.171,455.672,459.668,464.168,466.112,470.612,475.112,477.056,481.556,486.056,493.058,497.558,500.555,504.551,507.053,508.997,511.499,518.501,525.503,530.003,534.503,537.005,539.507,543.422,545.672" svgx:width="0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.39,0.5,0.5,0.5,0.5,0.33,0.28,0.39,0.25,0.28,0.5,0.44,0.25,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.5,0.44,0.39,0.44,0.5,0.25,0.5,0.5,0.25,0.5,0.5,0.78,0.5,0.33,0.44,0.28,0.25,0.28,0.78,0.78,0.5,0.5,0.28,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">positivity supports the use of therapy based on humoral immunity, </text>
   <text y="593.085" x="310.016,313.517,318.017,322.013,326.513,329.141,333.137,336.638,339.266,343.766,346.268,350.264,353.765,360.767,364.763,369.263,373.763,377.759,380.756,384.752,388.253,390.755,394.256,396.506,399.134,403.634,408.134,410.636,413.264,417.764,420.266,423.101,426.098,430.094,433.091,437.087,441.587,445.583,449.579,453.08,455.708,458.21,462.71,465.338,467.84,472.34,476.336,478.964,481.961,485.957,489.458,493.958,498.458,502.958,506.459,510.455,513.083,517.583,520.58,523.208,526.709,530.705,533.702,538.202,542.702" svgx:width="0.39,0.5,0.44,0.5,0.25,0.44,0.39,0.25,0.5,0.28,0.44,0.39,0.78,0.44,0.5,0.5,0.44,0.33,0.44,0.39,0.28,0.39,0.25,0.25,0.5,0.5,0.28,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.39,0.44,0.33,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">such as plasmapheresis, but differences in the response of seron-</text>
   <text y="604.083" x="310.016,314.012,318.512,322.508,325.01,327.512,332.012,336.008,338.258,342.758,346.754,349.256,351.758,355.754,360.254,362.756,366.257,368.507,372.503,375.5,379.496,381.746,386.246,390.746,395.246,398.243,400.745,405.245,407.495,411.995,415.991,419.492,423.488,426.485,428.987,433.487,437.483,441.983" svgx:width="0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.33,0.44,0.25,0.5,0.5,0.5,0.33,0.28,0.5,0.25,0.5,0.44,0.39,0.44,0.33,0.28,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">egative patients are poorly described.</text>
   <text y="615.081" x="310.016,317.018,322.022,325.019,329.015,333.011,336.008,338.51,343.01,347.006,350.507,353.504" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="615.081" x="359.192,364.061,368.561,370.811,374.249,378.245,382.745,386.741,389.243,393.743,397.739,400.241,404.237,406.487,409.925,412.427,416.927,420.923,423.173,426.611,430.607,433.442,436.439,438.941,442.937,446.933,450.929,455.429,457.679,461.117,465.113,469.613,474.113,476.363,479.801,483.302,487.298,490.295,494.291,496.793,501.293,503.543,506.981,511.481,514.478,516.728,520.166,524.666,527.168,531.164,534.665,541.667,545.663" svgx:width="0.61,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.28,0.44,0.39,0.78,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To evaluate the efficacy and safety of plasma </text>
   <text y="626.079" x="310.016,314.012,318.512,322.508,327.008,331.004,335.504,340.004,344.0,346.25,353.378,355.88,360.38,362.63,369.767,376.265,384.266,390.764,393.014,400.142,404.642,408.638,411.14,413.642,417.638,422.138,424.64,428.141,430.391,437.519,440.516,444.512,448.013,450.515,454.016,456.518,460.514,465.014,467.516,469.766,476.894,479.396,483.896,486.146,493.283,495.785,498.782,502.778,506.774,509.276,516.278,520.274,524.774,527.276,529.526,536.654,541.154,545.654" svgx:width="0.44,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.89,0.72,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.44,0.39,0.28,0.39,0.28,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">exchange in NMO patients resistant to treatment by </text>
   <text y="637.077" x="310.016,317.018,321.014,323.516,328.016,332.516,335.018,339.518,342.515,346.511,351.011,355.511,358.013,361.514,366.014,368.516,373.016,377.516,381.512" svgx:width="0.78,0.44,0.28,0.5,0.5,0.28,0.5,0.33,0.44,0.5,0.5,0.28,0.39,0.5,0.28,0.5,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">methylprednisolone.</text>
   <text y="648.075" x="310.016,318.512,322.508,325.505,330.509,335.009,340.013,343.514,346.511" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="648.075" x="349.643,355.646,357.896,358.778,363.278,366.275,370.775,374.276,378.776,382.772,386.768,389.27,391.772,396.272,400.268,402.518,403.4,407.396,411.896,415.892,418.394,422.894,426.395,428.897,432.398,434.648,435.53,440.03,443.027,445.277,446.159,450.659,455.159,457.409,458.291,462.791,466.787,469.289,471.791,475.787,480.287,482.789,486.29,488.54,489.422,495.92,498.422,500.924,505.424,507.674,508.556,515.054,523.055,529.553,531.803,532.685,536.681,541.181,545.681" svgx:width="0.72,0.25,0.55,0.5,0.33,0.5,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.72,0.89,0.72,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A prospective analysis of 16 patients with NMO and </text>
   <text y="659.073" x="310.016,316.514,324.515,331.013,336.017,342.515,345.044,348.041,352.541,357.041,361.541,366.041,368.57,373.07,375.572,379.568,384.068,388.568,393.068,396.569,399.071,401.573,405.569,408.098,412.094,415.091,417.593,420.095,424.091,427.088,429.59,433.586,436.583,439.112,442.109,446.105,449.102,452.099,456.095,460.091,462.593,467.093,470.09,474.59,477.119,479.621,484.121,486.65,493.652,497.648,500.15,504.65,509.15,511.652,516.152,519.149,523.145,527.645,532.145,534.647,538.148,542.648" svgx:width="0.72,0.89,0.72,0.56,0.72,0.25,0.33,0.5,0.5,0.5,0.5,0.25,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.28,0.44,0.25,0.44,0.33,0.28,0.28,0.44,0.33,0.28,0.44,0.33,0.25,0.33,0.44,0.33,0.33,0.44,0.44,0.28,0.5,0.33,0.5,0.25,0.28,0.5,0.25,0.78,0.44,0.28,0.5,0.5,0.28,0.5,0.33,0.44,0.5,0.5,0.28,0.39,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NMOSD (2006 diagnostic criteria) refractory to methylpredniso-</text>
   <text y="670.071" x="310.016,312.518,317.018,321.518,325.514,327.764,329.753,332.255,335.252,339.248,343.244,345.746,349.742,354.242,356.231,360.731,364.727,367.229,373.727,377.723,381.719,386.219,388.208,396.209,400.205,404.705,406.694,411.194,415.694,420.194,424.694,426.683,430.679,435.179,439.679,441.668,445.169,449.165,453.665,458.165,462.161,465.158,469.658,471.647,476.147,480.647,485.147,489.647,491.897,493.724,499.223,503.723,507.719,509.708,515.207,519.707,524.207,528.203,532.703,537.203,541.199,545.699" svgx:width="0.28,0.5,0.5,0.44,0.25,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.89,0.44,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.39,0.44,0.5,0.5,0.44,0.33,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.61,0.5,0.5,0.44,0.5,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lone, treated between May 2013 and January 2014. The Expanded </text>
   <text y="681.069" x="310.016,316.514,319.016,322.517,326.513,331.013,333.515,336.017,338.519,341.021,345.521,347.771,349.445,354.449,356.951,360.947,363.449,367.949,371.45,373.7,375.374,380.378,384.374,388.37,390.872,394.868,397.118,398.792,401.789,407.288,413.786,418.79,423.794,426.791,429.041,430.715,434.711,439.211,443.711,445.961,447.635,450.137,454.637,458.633,460.883,462.395,468.353,470.855,474.356,478.856,482.852,485.354,487.604,489.278,495.776,500.276,502.778,506.774,511.274,518.276,522.272,524.522,526.196,531.2,535.196,539.192,541.694,545.69" svgx:width="0.72,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.56,0.28,0.44,0.28,0.5,0.39,0.25,0.55,0.56,0.44,0.44,0.28,0.44,0.25,0.55,0.33,0.61,0.72,0.56,0.56,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.72,0.28,0.39,0.5,0.44,0.28,0.25,0.55,0.72,0.5,0.28,0.44,0.5,0.78,0.44,0.25,0.55,0.56,0.44,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Disability Status Scale (EDSS) and the Visual Outcome Scale </text>
   <text y="692.067" x="310.016,313.013,319.511,326.009,331.013,334.01,336.062,342.56,346.556,349.553,353.549,355.601,360.101,363.602,367.598,372.098,374.15,376.652,381.152,383.204,387.2,391.7,398.702,403.202,407.198,410.195,414.191,416.243,419.24,423.236,426.737,431.237,433.739,436.241,439.742,441.794,446.294,450.794,453.296,457.796,459.848,464.348,467.345,471.341,474.338,476.39,480.386,484.886,489.386,491.438,495.938,500.438,503.939,506.441,509.438,511.94,514.937,518.933,522.929,525.431,532.433,536.429,540.929,543.431,545.681" svgx:width="0.33,0.72,0.72,0.56,0.33,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.25,0.33,0.44,0.39,0.5,0.28,0.28,0.39,0.25,0.5,0.5,0.28,0.5,0.25,0.5,0.33,0.44,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.39,0.28,0.33,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(VOS) were used to compare results both pre- and post-treatment. </text>
   <text y="703.065" x="310.016,316.514,320.51,324.506,329.006,333.002,337.502,340.499,344.0,346.34,350.336,353.333,355.835,358.337,362.333,365.33,367.832,371.828,374.168,380.666,384.662,387.659,391.655,393.995,397.991,401.492,404.993,409.493,413.489,415.991,419.987,422.489,426.485,430.985,433.325,435.827,440.327,442.667,446.663,450.164,453.665,457.661,461.162,464.663,467.003,469.505,476.507,481.007,484.004,488.504,493.004,497.0,504.002,507.998,512.498,515.0,517.34,519.842,524.342,526.682,529.679,534.179,538.679,542.675" svgx:width="0.72,0.44,0.44,0.5,0.44,0.5,0.33,0.39,0.25,0.44,0.33,0.28,0.28,0.44,0.33,0.28,0.44,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.28,0.5,0.25,0.33,0.5,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Keegan´s criteria were associated to assess improvement in func-</text>
   <text y="714.063" x="310.016,312.518,315.02,319.52,324.02,328.016,330.518,333.02,335.522,339.437,341.687,344.135,349.139,353.135,355.637,358.139,362.135,366.635,369.137,372.638,375.086,381.584,385.58,388.577,392.573,395.021,399.017,403.517,407.513,410.015,414.515,418.511,421.013,425.009,429.509,431.957,435.953,438.455,440.903,443.405,447.905,450.407,454.403,457.4,461.9,465.896,468.398,471.899,474.347,477.344,479.846,484.346,488.342,492.842,495.29,499.79,502.787,506.783,509.033,511.481,515.981,518.231,520.679,525.179,529.679,531.929,534.377,538.877,543.377,545.627" svgx:width="0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.25,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.44,0.28,0.25,0.28,0.5,0.28,0.44,0.33,0.5,0.44,0.28,0.39,0.25,0.33,0.28,0.5,0.44,0.5,0.25,0.5,0.33,0.44,0.25,0.25,0.5,0.25,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tionality. Patients were evaluated at intervals fixed pre, 1, 15, 30, </text>
   <text y="725.061" x="310.016,314.516,319.016,321.266,325.262,329.762,334.262,336.512,341.012,345.512,347.762,352.262,356.258,360.758,364.259,366.509,370.505,373.502,376.004,380.0,382.997,385.247,389.747,392.249,396.245,399.746,406.748,410.744,415.244,419.744,423.74,426.737,430.733,434.234,436.736,440.237" svgx:width="0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.25,0.5,0.44,0.5,0.39,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.5,0.28,0.44,0.39,0.78,0.44,0.5,0.5,0.44,0.33,0.44,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">60 and 90 days after plasmapheresis.</text>
  </g>
 </g>
</svg>
